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ABSTRACT 
 
Choline is an essential nutrient for humans. It participates in many important 
physiological processes including membrane signaling/integrity, neurotransmission, 
methylation, and lipid transport. Since choline is a precursor to acetylcholine (ACh), a 
neurotransmitter that mediates muscle contraction, studies have been conducted to 
examine the relations between choline intake and endurance exercise performance. 
However, the results were equivocal, mostly due to lack of nutritional control, and there 
has been no study that examined the effects of choline associated with resistance 
exercise (RE). 
The purpose of this research was to investigate the effects of dietary choline on 
muscle responses to RE in three study populations. It was hypothesized that low choline 
consumption would negatively influence changes in lean mass and strength in response 
to RE in older adults. 
The first study examined the effects of habitual choline intake in the context of 
commonly recommended “healthy eating”, on changes in strength and lean mass 
following 12 weeks of full body resistance exercise training (RET). The results showed 
that lower intake of choline (<50% of Adequate Intake [AI]) was associated with 
significantly diminished gains in strength and lean mass compared with higher choline 
intakes (~63% or ~85% of AI). 
The second study investigated the effects of choline supplementation from egg 
yolk for 12 weeks on muscle responses to RET in a randomized double-blind placebo-
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controlled trial. The results showed that lower (~51% of AI) choline consumption 
significantly impaired strength but not muscle gains compared with moderate choline 
intake (~68% of AI) while higher (~118% of AI) choline intake did not provide 
additional benefits on strength gains. 
The third study examined the effects of choline supplementation for 3 weeks on 
EMG amplitude and strength responses. No choline effect was observed on isometric 
force outputs, maximum strength on leg press/leg extension, or EMG amplitudes. 
The results of these studies suggest that only lower choline intake (~50% of AI) 
for more than one month may negatively affect change in strength associated with RET. 
Consumption of varying amounts of choline for a short period or higher than 
recommended amounts of choline may not influence muscle responses to RE. 
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CHAPTER I 
INTRODUCTION 
 
Age related loss of muscle mass (sarcopenia) and the associated decline of 
strength, force, functionality, and mobility is a serious issue in the U.S. where the 
population over the age of 65 is expected to increase steadily from 14.9% in 2015 to 
23.6% by 2060 (1). Fortunately, resistance exercise has been shown to delay and/or 
reverse the detrimental effects of sarcopenia, and the efficacy and efficiency of 
resistance exercise programs can be influenced by dietary intakes of various nutrients 
such as protein and carbohydrate as well as micronutrients including vitamins and 
minerals (2, 3). 
Choline is an important micronutrient playing vital roles in many physiological 
processes including cell membrane formation/integrity/signaling, lipid transport, and 
methylation/reduction of homocysteine. Choline deficiency is known to cause 
liver/muscle damage, steatosis (fatty liver), birth defects, and cognitive dysfunction. 
Choline is also a precursor to acetylcholine (ACh), the main neurotransmitter in α-motor 
neurons, which control muscle contraction and force generation, and ACh production 
and release is dependent on available choline levels (4, 5). Therefore, dietary choline 
may affect exercise performance and responses to exercise by mediating availability of 
ACh at the neuromuscular junction (NMJ) and/or through other mechanisms such as its 
roles as a structural component of membranes and its effects on cell signaling, lipid 
metabolism, methylation reactions, and oxidative stress (6-10).     
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Several studies have examined the relationship between dietary choline 
consumption, blood choline levels, and exercise performance, but the results are 
equivocal. Exercises with prolonged duration and high in intensity such as marathon 
runs and 2 hour long high speed bicycle riding decreased blood choline levels, but the 
effects of decreased blood choline concentration on exercise performance were unclear 
or not measured (11-13). Other types of exercises (treadmill or cycling at moderate 
intensity) did not affect blood choline concentrations (14, 15), and choline 
supplementation prior to exercises did not improve exercise performance even though 
the supplementation either prevented a drop in blood choline or increased choline 
concentrations (13-17). 
However, many of these studies lacked nutritional control and/or only examined 
the effects associated with acute endurance type of exercises, leaving the effects of 
choline intakes on resistance exercise (RE) and training responses largely unknown. The 
low frequency α-motor neuron output and lower number of total motor units activated 
during endurance exercise may allow sufficient time to re-synthesize ACh. Conversely, 
the high frequency α-motor neuron output and increased number of active motor units 
during RE may limit ACh availability and influence neural activation, muscle 
contraction, and force generation. Currently, there is no study that examined the effects 
of dietary choline on RE and training responses. Even though some of the 
aforementioned exercise studies utilized a barbell squat, push-ups, or sit-ups in their 
exercise protocols, the exercise loads used were very light (either a 45 kg barbell or body 
weight only), therefore, it is difficult to regard those as RE (15, 18). 
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Despite the importance in human health and physiology, data suggest that 
choline intakes are lower than recommended values (Adequate Intakes [AI] of choline: 
550 mg/d and 425 mg/d for adult men and women, respectively) (19) in general public 
and especially in older adults. A recent data analysis of National Health and Nutrition 
Examination Survey (NHANES) 2007-2010 shows that mean daily intakes of choline in 
men and women between the ages of 51 and 70 years were 396 mg and 274 mg, 
respectively, and more than 90% of these individuals consumed less than the 
recommended amounts of choline (20, 21). Yonemori et al. (22) also reported that the 
mean choline intakes of 188,147 subjects aged between 45 and 75 were 372 mg/d in men 
and 304 mg/d in women. The prevalence of low choline intake in older adults may have 
devastating effects if choline influences responses to RE, which is one of the most 
effective means to delay or counter the effects of aging on muscle mass and strength in 
older population (2). 
The purpose of this dissertation was to examine the effects of dietary choline on 
exercise performance and physiological responses to RE in older adults. Considering the 
detrimental effects of sarcopenia, it is important for these individuals to regularly 
perform RE and maintain optimal nutrient intakes (3).  
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CHAPTER II 
BACKGROUND 
 
Property and Physiological Roles 
Structure and Sources of Choline 
Choline was first discovered in 1862 by Adolph Strecker via heating lecithin 
(phosphatidylcholine [PC]) obtained from bile of pig and ox (23). Choline is a water 
soluble quaternary ammonium cation with the chemical formula of (CH3)3N
+(CH2)2OH,  
and it usually exists as an ionic compound combined with various type of anions such as 
chloride, tartrate, hydroxide, or phosphate. (Figure 1). 
 
 
 
    Figure 1. Chemical Structure of Choline 
 
 
There are two sources of choline for humans: dietary intake and endogenous de 
novo synthesis (Figure 2). Choline from foods (exogenous choline) is absorbed in the 
intestine via choline transporters and promptly converted to phosphocholine by choline 
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kinase, or betaine by choline oxidase/choline dehydrogenase (CHDH) and betaine 
aldehyde dehydrogenase (BADH) reactions (24). Phosphocholine is converted to 
cytidine diphosphocholine (CDP-choline) by CTP:phosphocholine cytidylyltransferase 
enzyme, and PC is synthesized from CDP-choline by CDP-choline:1,2-diacylglycerol 
choline phosphotransferase. PC is the most abundant phospholipid (>50%) in all cellular 
membranes and the major form of choline reservoir in animals. Approximately 95% of 
the total choline exists in the form of PC, and the remaining 5% exists as free choline, 
phosphocholine, glycerophosphocholine, CDP-choline, or ACh (24). PC is then broken 
down to phosphatidic acid (PA) and choline by phospholipase D (PLD). 
 
 
 
     Figure 2. Pathways of PC and Choline Synthesis (24) 
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Choline (endogenous choline) can be also obtained from PC synthesized de novo 
from phosphatidylethanolamine (PE). PE is sequentially methylated by 
phosphatidylethanolamine N-methyltransferase (PEMT) enzyme and S-adenosyl 
methionine (SAM) to be converted to PC in the liver. Choline can then be generated 
from PC by phospholipase enzymes. Animal models showed that approximately 70% of 
hepatic PC is produced via CDP-choline pathway, and PEMT pathway accounts for the 
remaining 30% (24), but since PEMT activity is meaningfully active only in the liver, it 
is estimated that 85% of total required choline is obtained from diet and 15% is 
synthesized endogenously in rodents (25). However, when choline intake is low, and 
perhaps when choline use is elevated, PEMT pathway can play an important role to 
compensate for the insufficient amount of choline and PC (24). 
 
Membrane Integrity/Signaling 
Choline is a critical component of PC, which is the most abundant phospholipid 
and major constituent of all cellular membranes and pulmonary surfactant. PC is also a 
precursor to signaling molecules such as PA, which is required to activate mammalian 
target of rapamycin (mTOR) that plays a critical role in protein synthesis and cell 
growth/proliferation (26). PC can be converted to sphingomyelin or phosphatidylserine, 
and choline is needed to make lysophosphatidylcholine and choline plasmalogen, which 
are also essential components of all cellular membranes. Choline deficient diet results in 
compromised cell membranes, and intracellular enzymes can leak from liver and muscle 
cells. da Costa et al. (6) reported that serum creatine kinase (CK; a marker of muscle 
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damage) increased by 33-66 fold in three of four male subjects who were fed a choline 
deficient diet (50 mg/70 kg/d), and the increase in CK was reversed with higher choline 
intake during a recovery period. The study also observed 3.5 times more CK leaked from 
mouse myoblasts incubated in choline deficient medium compared with control. Also, in 
the cells grown in choline deficient environment, apoptosis was induced, and reduced 
concentrations of PC, choline, phosphocholine, and glycerophosphocholine, and higher 
membrane osmotic fragility were observed (6). 
 
Bile and Lipoprotein Secretion 
Choline in the form of PC is required for bile secretion from the liver. 5% of PC 
in bile is excreted as feces, and 95% is reabsorbed in the intestines, but only 40% of the 
reabsorbed PC returns to the liver for recycling (27). Choline is also used to package and 
export triacylglycerol (TAG) into very low density lipoprotein (VLDL) from the liver. 
Both the CDP-choline pathway and the PEMT pathway are required to produce PC for 
VLDL secretion in the liver (9, 24). Therefore, dietary choline is a necessary component 
for VLDL synthesis. 
 
Methylation/One Carbon Reaction 
A portion of choline can be irreversibly converted to betaine by CHDH and 
BADH reactions (Figure 3). Betaine is then used to convert homocysteine to methionine 
by betaine homocysteine S-methyltransferase (BHMT). Methionine is used to generate 
SAM, which is a universal methyl donor in various biochemical reactions including 
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synthesis of DNA, RNA, carnitine, creatine, and epinephrine. Therefore, choline plays 
an important role in methylation/one-carbon reaction in mammals. Methylation is a key 
component in many physiological reactions such as lipid biosynthesis, epigenetic control 
of gene expression/protein synthesis, and regulation of metabolic pathways (10, 28). 
 
 
 
Figure 3. Metabolic Pathway of Choline (29) 
 
 
Neurotransmitter Synthesis 
Choline is a precursor to ACh, a neurotransmitter which allows cholinergic 
nerves to communicate with other cells, and relays signals from motor neurons to 
skeletal muscles. ACh is synthesized from acetyl-CoA and choline by choline 
acetyltransferase (ChAT). Once released from nerve endings, ACh is diffused through 
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synaptic cleft (a gap between nerve ending and other tissues such as muscle or other 
nerves) and binds to ACh receptors on the surface of other cells. This produces rapid 
flux of ions across membranes and generates depolarization/action potentials (30). ACh 
is then catabolized by ACh esterase to acetate and choline, which can be taken up by 
choline transporters on the nerve ending and recycled. Studies showed that availability 
of choline in surrounding environment affects ACh synthesis and release from nerve 
endings (5). For example, Bierkamper and Goldberg (4) reported that the amount of ACh 
release in nerve ending was directly related to the concentration of available choline in a 
vascular perfused rat phrenic nerve-hemidiaphragm. As the concentration (µmol) of 
choline in the perfusate increased from 0 to 30, and to 60, ACh release (pmol/min) was 
increased from 5.13 ± 0.6 to 6.75 ± 0.1, and to 9.78 ± 1.7, respectively, in response to 
electrical stimulation (7 Hz) of the phrenic nerve (4).  
 
Reduction of Oxidative Stress and Increased Fatty Acid Oxidation 
Choline may also play a role in reducing oxidative stress in humans. Sachan et al. 
(7) reported that one week of choline supplementation (0.94 g/d) resulted in marked 
decrease in serum thiobarbituric acid reactive substances (TBARS; a biomarker of 
oxidative stress) in 18-54 year old women, which occurred most likely by preventing 
membrane fatty acid peroxidation and stabilization of membranes (7). When choline and 
L-carnitine was supplemented together, an antioxidant sparing effect was also observed. 
After two weeks of choline/L-carnitine supplementation, serum concentrations of retinol 
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and α-tocopherol were significantly higher in the supplement group than placebo group, 
suggesting less oxidative damage had occurred in the supplement group (7). 
Increased choline consumption may also increase fatty acid oxidation through its 
effect on carnitine conservation. In humans and guinea pigs, supplementation of choline 
decreased urinary excretion of carnitine and increased uptake of carnitine in all tissues 
including skeletal muscle. The functional implications of increased cellular uptake and 
accretion of carnitine may be increased fatty acid oxidation and possibly reduction of 
body fat (8, 31). 
Intertwined with Other Nutrients 
Choline is interconnected with other nutrients such as folate, methionine, B 
vitamins, and glycine at the point of conversion of homocysteine to methionine (Figure 
3). As discussed, a portion of choline is converted to betaine, which is used to convert 
homocysteine to methionine (BHMT pathway), but there is another pathway (methionine 
synthase [MS] pathway) that performs the same task. Methyl tetrahydrofolate (methyl-
THF) donates methyl group to homocysteine in a reaction catalyzed by MS and vitamin 
B12, and this reaction produces methionine and THF. Methionine is used to make SAM, 
which is, after donating a methyl group, converted to S-adenosylhomocysteine (SAH), 
which is, in turn, converted back to homocysteine. THF is also converted back to 
methyl-THF, and folate is needed to produce THF. Homocysteine can also be converted 
to cysteine by cystathionine synthase and vitamin B6. Cysteine can then be used to 
produce glutathione, and glycine and serine are needed in the process. Therefore, 
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activation of one pathway can decrease the reliance on the other pathways, and 
deficiency of one nutrient can increase the requirement of the other nutrients. Thus, 
choline, betaine, folate, vitamin B12, vitamin B6, methionine, serine, and glycine are all 
interconnected with each other, and higher intake of one nutrient may induce sparing 
effects of other nutrients. 
Choline as an Essential Nutrient 
AI for Choline 
Since there exists a pathway for endogenous synthesis (mainly in liver), choline 
was not considered an essential nutrient for humans for a long time, and it was thought 
choline requirement can be met with de novo synthesis in humans. However, 
endogenous synthesis alone has since been demonstrated to be insufficient for several of 
choline’s functions. For example, Burt et al. (32) reported that total parenteral nutrition 
(TPN), which does not contain choline, caused a significant drop in plasma choline 
levels and increase in alanine aminotransferase (ALT; a marker of liver damage) in 
blood. Buchman et al. (33) observed that hepatic steatosis in patients receiving TPN was 
completely resolved with administration of choline. Also, Zeisel et al. (34) found that 3 
weeks of choline-deficient diet (with normal folate, methionine, and vitamin B12) in a 
hospital setting lowered plasma choline and PC concentrations by 30%, and increased 
serum ALT levels by 48% in healthy males, and these changes were quickly reversed 
within one week after the subjects started to consume a normal diet. 
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As a result of accumulation of study data supporting the importance of choline 
intake, the Food and Nutrition Board of the Institute of Medicine (IOM), National 
Academy of Sciences, established AI values for choline (Table 1) in 1998 (19, 35, 36), 
but Recommended Dietary Allowance (RDA) has not been established yet. Both AI and 
RDA are parts of Dietary Reference Intakes (DRI), which are reference values for 
healthy people to plan and assess their diets, but RDA is a nutrient intake level sufficient 
to meet 98% of healthy individuals’ diet requirement, whereas AI is a nutrient intake 
goal used when sufficient scientific data do not exist to set RDA (35). More studies are 
needed to establish DRI values that accurately reflect various conditions which may 
require elevated choline consumption such as physical activities, mental stress, and 
recovery from illness/injury. 
  Table 1. AI for Choline (37) 
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Individual Variability in Dietary Choline Requirement 
The current AI values of choline are set at the levels of intake which are expected 
to be sufficient to prevent liver dysfunction (determined by increased serum ALT levels; 
~7 mg/kg/d) in sedentary people without consideration of physical activity levels (35). 
Therefore, it is possible that active individuals may need elevated choline intake because 
physical activities require increased ACh synthesis/release, lipid oxidation/metabolism, 
membrane integrity, and methylation reactions, and choline plays vital roles in many of 
these important physiological processes. 
However, there is evidence that the current AI may not be sufficient to prevent 
choline deficiency in some individuals. For example, Fischer et al. (38) reported that 6 of 
26 male subjects (23%) showed signs of liver/muscle damage (5 fold increase in serum 
CK; 1.5 fold increase in ALT, aspartate aminotransferase [AST], gamma-glutamyl 
transferase [GGT], or lactate dehydrogenase [LDH]; or >28% increase in liver fat 
content) when they were fed a diet containing 550 mg/70 kg/d of choline (~100% AI) for 
10 days in a hospital setting. 
Also, it appears that there exists a great variability in choline requirement among 
individuals. In the same study, the subjects were fed a choline deficient diet (50 mg/70 
kg/d; <10% of AI) for up to 42 days in a hospital setting. However, 6 of 26 men, 3 of 15 
postmenopausal women, and 9 out of 16 premenopausal women did not show any signs 
of choline deficiency. When the remaining subjects who developed the symptoms of 
choline deficiency were fed a repletion diet with gradually increasing the amount of 
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choline in their foods, 10, 3, and 5 of them needed choline intakes at 25%, 50%, and 
75% of AI to reverse the conditions of choline deficiency, respectively (38). It appears 
that some individuals are more tolerant of low choline intake than others, possibly 
through variability in choline use and/or variation in the ability to synthesize choline 
endogenously in the liver. 
Effects of Gender and Genetic Variations 
As discussed earlier, choline can be synthesized de novo from PE by PEMT and 
SAM. PEMT gene, which codes for PEMT enzyme, has estrogen response elements, and 
estrogen induces PEMT gene expression and increases PEMT enzyme activity in a dose-
dependent manner (39). This may explain why premenopausal women are more resistant 
to choline deficiency than men and postmenopausal women. Fisher et al. (38) reported 
that almost 80% of men and postmenopausal women showed signs of choline deficiency 
in response to a severely low choline diet (<10% AI) while only 44% of premenopausal 
women became choline deficient in their hospital setting study. Another study (40) also 
observed the effect of estrogen on dietary choline requirement and susceptibility to 
choline deficiency. It reported that only 18% of postmenopausal women with estrogen 
treatment developed organ dysfunction while 73% of those who received placebo 
showed signs of organ dysfunction, when they consumed a low choline diet (40). 
Also, there is evidence suggesting that individual choline requirement is 
dependent on one’s genetic predisposition. In their 2006 study, da Costa et al. (41) 
identified single nucleotide polymorphism (SNP) in PEMT gene and examined the effect 
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of the SNP on susceptibility to choline deficiency. They recruited 57 males and females 
aged between 18 and 70 and had them consume a low choline diet (<50 mg/70 kg/d) for 
up to 42 days or until they developed signs of organ dysfunction. They found that 18 of 
23 women and 11 of 13 postmenopausal women with an SNP in PEMT gene (-744 
G→C; rs12325817) developed organ dysfunction (41). Fischer et al. (40) also reported 
that 80%, 43%, and 13% of premenopausal women with 2, 1, and 0 variant alleles of the 
SNP on PEMT gene showed signs of organ dysfunction with a very low choline diet, 
respectively. 
Other SNPs in different genes were also identified. An SNP (+318 A→C; 
rs9001) in CHDH gene, which codes for CHDH enzyme, had a protective effect in all 
the subjects, and another SNP in CHDH gene (+432 G→T; rs12676) increased 
susceptibility to organ dysfunction in premenopausal women (41). More recently, 
additional SNPs (in choline kinase A/B [CHKA, CHKB] and solute carrier 44A1 
[SLC44A1] genes, which affect PC synthesis from choline and transport of choline 
across membranes) that affect requirement of dietary choline were discovered, and these 
SNPs appear to vary in their distribution across ethnic/racial groups, confirming the 
effect of genetics on choline metabolism and dietary requirement (42). While the 
influence of genetics makes it difficult to accurately estimate individual choline 
requirements, da Costa et al. (42) suggest that setting the dietary recommendations of 
choline at higher levels would be the most practical solution that ensures enough choline 
intake for all populations including those who may have greater choline requirement due 
to their genotypes and other factors. 
16 
Dietary Sources of Choline 
The US Department of Agriculture (USDA) developed and released a database 
for choline in collaboration with University of North Carolina in 2004 and 2008 (43, 44). 
According to the most recent version that contains choline and other choline containing 
compounds in more than 630 food items, choline is abundant in animal foods in general 
(Table 2), especially in eggs and organ meats (44). Egg yolk is by far the most 
concentrated source of dietary choline, providing 680 mg/100 g, and beef liver (330 
mg/100 g), chicken liver (190 mg/100 g), turkey liver (220 mg/100 g), smoked sockeye 
salmon (220 mg/100 g), beef chuck (100 mg/100 g), and defatted soy flour (190 mg/100 
g) are some of the most choline-rich foods, according to the USDA database (44).
17 
 Table 2. Foods High in Choline (29) 
Prevalence of Low Choline Intake 
Despite the importance of choline as an essential nutrient, data indicate that 
majority of general public do not consume adequate amount of choline from their diet. A 
recent analysis of NHANES 2011-2012 (45) shows that mean daily intakes of choline in 
men and women with 20 years of age and older are 402 mg and 272 mg, respectively. 
Xu et al. (46) reported that the mean and median choline intake values in 3,064 subjects 
residing in Long Island, NY were 325 mg/d and 321 mg/d, and Chiuve et al. (47) found 
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that 80% of their 1,477 women subjects consumed less than 361 mg/d of choline. Also, 
920 men and 1,040 women (mean age: 54 years with a range of 28-82 years) in 
Framingham Offspring Study consumed 313 mg of choline per day on average, and only 
20% of them had daily choline intakes of >401 mg (48). Another data analysis showed 
that older adults with >70 of age consume only 264 mg/d of choline on average (29). 
The prevalence of low choline intake may be attributed to the current diet 
guidelines’ effect. The foods rich in choline (eggs and other animal foods) are also rich 
in cholesterol and/or saturated fat in general, and the diet guidelines recommending 
limited intakes of those foods have been in place for decades, and changes are beginning 
to occur only recently. In their Scientific Report recently submitted to the U.S. 
Department of Health and Human Services (HHS) and USDA, the 2015 Dietary 
Guidelines Advisory Committee said cholesterol intakes do not need to be limited while 
they recommend reduced consumption of red meat and saturated fat (20). 
Choline Deficiency 
Choline deficiency, especially when coupled with insufficient consumption of 
methionine and/or folate, can lead to many diseases and critical unhealthy conditions. 
Non-Alcoholic Fatty Liver Disease (NAFLD) 
Insufficient consumption of choline can result in fatty liver even with adequate 
levels of folate and methionine intake (33, 37, 38).  Since choline and PC is required to 
package and export TAG as VLDL, choline deficiency impairs VLDL secretion, and this 
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in turn, leads to accumulation of TAG in hepatocytes (37). Other mechanisms for 
development of fatty liver associated with choline metabolism have been suggested 
recently (49). Aberration of PEMT pathway and/or methylation function (50), impaired 
mitochondrial function and beta oxidation through perturbation of mitochondrial 
membranes (51), and endoplasmic reticulum stress (52) are all related to NAFLD. Fatty 
liver is an early indicator of liver dysfunction and can progress to hepatitis, fibrosis, 
cirrhosis, and cancer (49). 
Birth Defects / Neural Tube Defects 
Folate deficiency is known to be associated with neural tube defects. However, 
evidence indicates that dietary choline intake may also be linked to neural tube defects. 
Inhibition of choline uptake/metabolism resulted in growth retardation and defects in 
neural tube in mouse embryo models (53), and Shaw et al. (54) reported that higher 
choline intake (>498.46 mg/d) during pregnancy has 50% less risk of inducing neural 
tube defects compared with lower choline intake (<290.41 mg/d). The authors suggested 
that perturbation of DNA methylation and/or increased apoptosis resulted from choline 
deficiency may be the underlying mechanism for the neural tube defects (54). 
Cancer 
Choline deficiency may even be related to cancer. Xu et al. (46) reported that 
higher intake of choline (>455.8 mg/d) was associated with 24% lower risk of breast 
cancer compared with lower choline intake (<196.5 mg/d) in their 2008 population-
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based study. They suggested that aberrant DNA methylation resulted from low choline 
intake may be the underlying mechanism. Indeed, several studies showed that choline 
deficiency is related to membrane integrity, DNA damage, and apoptosis (6, 55).  When 
choline supply from diet is insufficient, PEMT pathway can be enhanced to produce 
required choline and PC from PE. However, this may result in shortage of SAM. The 
conversion of PE to PC uses three molecules of SAM, which is to be used for 
methylation of various other molecules including DNA and RNA. This might be linked 
to aberrant DNA methylation. 
Homocysteine/Cardiovascular Disease 
Reliance on PEMT pathway also produces three molecules of SAH, which is 
then broken down to adenosine and homocysteine. Homocysteine disrupts endothelial 
function and is an independent cardiovascular risk factor (56), therefore, limited 
consumption of choline may influence cardiovascular risks by relying more on PEMT 
pathway of choline synthesis and generating more homocysteine, or low choline intake 
may simply reduce the availability of betaine, which is used to convert homocysteine to 
methionine. Choline deficiency has been shown to increase blood concentrations of 
homocysteine. For example, in choline deficient mice and humans, blood homocysteine 
levels were twice greater in mice and 35% higher in humans in response to methionine 
load, compared with control (57). Chiuve et al. (47) observed blood homocysteine level 
was 8% lower in women who consumed more choline and betaine than in women with 
lower choline and betaine consumption. Also, Olthof et al. (58) examined the effect of 
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choline supplementation on plasma homocysteine levels in 26 men with a cross over 
design. When the subjects consumed 2.6 g/d of choline for 2 weeks, fasting plasma 
homocysteine levels were 18% lower compared with placebo consumption (58).  
Tolerable Upper Intake (UL) 
IOM also set UL levels for choline. UL is the highest level of daily intake for 
almost all individuals without risks of adverse health effects. The current UL values for 
choline are: 1.0 g/d for 1-8 year olds, 2.0 g/d for 9-13 year olds, 3.0 g/d for 14-18 year 
olds, and 3.5 g/d for 19 years and older (19, 35). Too much choline consumption 
exceeding liver’s ability to oxidize trimethylamine (TMA), a product of bacterial 
degradation of choline in intestines, and/or inability to properly metabolize TMA in liver 
by amine oxidase enzyme, can result in fish odor syndrome (trimethylaminuria), where 
offensive smell of rotten fish emanates from one’s body (59).  Also, a recent study 
suggests that too much choline consumption (more than 5 to 10 times of normal intake 
values) may be related to development of atherosclerosis, depending on individual’s 
intestinal microbial environment (60). 
Choline and Exercise 
Since choline is a precursor to ACh, which relays signals from the nerves to 
skeletal muscles and thus controls muscle contraction, interest among exercise scientists 
about the roles of choline has arisen, and as a result, several studies have been conducted 
to examine the effects of choline associated with exercise and performance. ACh is 
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synthesized in cholinergic neurons from acetyl-CoA and choline by ChAT enzyme, and 
ACh synthesis and release from nerve endings can be affected by the availability of 
choline. 
As discussed earlier, Bierkamper and Goldberg (4) showed that the release of 
ACh in response to electrical stimulation increased by 32% and 89% when the 
concentrations of choline in the perfusate increased from 0 µM to 30 µM, and to 60 µM, 
respectively, in vascular perfused hemidiaphragm-phrenic nerve preparation of rat. The 
similar results were observed in different tissues suggesting ACh synthesis is dependent 
upon the availability of choline. Haubrich et al. (61) reported that intravenously 
administered choline chloride resulted in rapid increase in ACh in adrenals, kidney, lung, 
and liver of guinea pigs. Cohen and Wurtman (62) observed that concentrations of ACh 
in the brain were 28% and 45% higher in the rats that consumed 20 mg/d and 129 mg/d 
of choline, respectively, for 11 days compared with the animals that did not consume 
choline. Therefore, it is reasonable to hypothesize that increase in choline levels may 
increase ACh synthesis and release, and reduced choline concentrations may decrease 
ACh release and consequently affect exercise performance especially at high rates of 
muscle contraction with large muscle groups involved. 
Exercise and Blood Choline Levels 
Researchers hypothesized that since physical activities increase nutritional 
demand, exercise may decrease circulating choline levels, and this, in turn, may 
negatively influence exercise performance. Conlay et al. (11) measured blood 
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concentrations of choline prior to and immediately after a marathon run in 1986 Boston 
Marathon participants. Running the marathon reduced the blood choline levels by 40% 
on average, from 14.1 ± 1.2 µM to 8.4 ± 0.6 µM (11).  The decrease in blood choline 
with an acute bout of exercise was also observed in a different group of marathon 
runners. In 1997, choline concentrations in plasma were measured before and after a 
marathon in 23 male and female runners aged 25 to 49 years (12). Plasma choline levels 
decreased from 19.2 ± 4.5 µM to 14.6 ± 4.2 µM and from 2,565.2 ± 516.4 µM to 2,403.4 
± 643 µM, respectively, following a marathon. However, the changes in plasma choline 
levels were not correlated with performance (finish time), which might be expected 
considering the large number of factors influencing a marathon performance. The same 
research group measured blood choline levels again before and after another marathon 
race in 2,000, and observed decreases in blood choline concentration (from 9.6 ± 2.5 µM 
to 7.0 ± 3.6 µM) following a marathon in trained athletes (17). The decrease in blood 
choline was also observed in elite triathletes. In a study with top level triathletes, the 
mean plasma choline concentration dropped by 16.9% (from 12.08 ± 0.54 µM to 10.04 ± 
0.72 µM) after 2 hours of bicycle exercise at the speed of 35km/h (13). 
However, there are several other studies that failed to observe decrease in blood 
choline levels in response to exercise. Spector et al. (14) reported that in young trained 
male cyclists, acute bouts of either sprinting exercise on cycle ergometer at 150% of 
VO2max until exhaustion (for approximately 2 minutes) or prolonged cycling exercise at 
70% of VO2max until exhaustion (for approximately 75 minutes) did not induce 
decrease in blood choline levels. Similarly, von Allworden at al. (13) found no 
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difference in choline concentrations between pre-exercise and post-exercise plasma 
samples when elite level adolescent athletes (aged 14-20 years) ran 30-60 minutes of 
cross country races. Warber et al. (15) also examined the effect of strenuous and 
prolonged exercises on blood choline levels. They had highly trained soldiers walk on a 
treadmill at the speed of 5.6 km/h for 4 hours carrying 34.1 kg of load (at intensity of 
38% of VO2max). At the completion of the treadmill walk, after removing the load, they 
underwent a run-to exhaustion test on a treadmill. The blood choline level did not drop 
with the 4 hour-long load carriage walk and run test. A similar load carriage exercise did 
not reduce blood choline levels in a different group of soldiers. In their 2002 study, 
Deuster et al. (16) reported that 1.5 hour treadmill load carriage exercise at 70% of 
VO2max did not affect blood choline concentrations in young soldiers. 
These results suggest that not all exercises can lower blood choline levels, and it 
appears that only those exercises that are both very high in intensity and long in duration 
(such as marathon) can reduce blood choline levels. Either performing exercises with 
moderate intensity for an extended time or engaging in physical activities with high 
intensity for short duration does not seem to affect blood choline concentrations. 
However, these studies did not examine the effect of decreased blood choline 
concentration on exercise performance at all or in a precise way. Thus, it is unclear 
whether lower levels of circulating choline negatively affect exercise performance. The 
only reported outcome was finish time of a marathon race, which was not correlated with 
plasma choline levels (12), but it is difficult to draw a conclusion from this result, 
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because many other confounding factors such as body composition, age, training history, 
and nutritional intakes were not controlled. 
Choline Supplementation and Exercise Performance 
Another important scientific question is whether increasing choline intake has 
any effect on blood choline concentrations and/or exercise performance, and this has 
inspired several exercise studies using choline as a supplement. In a randomized, 
placebo-controlled, crossover study, von Allworden et al. (13) recruited 10 triathletes 
with 23-28 years of age (6 males and 4 females) and had them perform a 2 hour long 
bicycle exercise at the speed of 35km/h with and without pre-exercise lecithin 
supplement (0.2 g lecithin [90% PC; 12% choline]/kg body weight, consumed 1 hour 
prior to exercise). The athletes also consumed the same supplement without exercise as a 
control in a separate occasion. The authors reported that the 2 hour cycling without 
lecithin supplement resulted in 17% drop in blood choline concentration while the 
supplement prevented the decrease in blood choline levels (pre-exercise: 10.76 ± 0.23 
µM vs. post-exercise: 11.10 ± 0.24 µM). When the subjects consumed the supplement 
without exercise, their blood choline levels increased by 27% on average. The authors 
also had 13 adolescent athletes (age 14-20, 3 girls and 10 boys) run a 30-60 minute 
cross-country race with and without the same lecithin supplement. After exercise, the 
mean plasma choline levels increased by 18.4% compared with the pre-exercise values 
(from 13.85 ± 0.60 µM to 16.25 ± 0.76 µM) when the subjects consumed the pre-
exercise supplement while the subjects’ plasma choline levels remained largely 
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unchanged with placebo consumption (pre-exercise: 14.51 ± 0.81 µM vs. post-exercise: 
14.95 ± 0.46 µM). When the subjects took the supplement without exercise, the mean 
plasma concentrations increased from 14.15 ± 0.24 µM to 21.75 ± 0.71 µM (54% on 
average). The results showed that choline supplementation prior to exercise can maintain 
or increase blood choline concentrations in endurance trained athletes (13). 
To examine the effects of choline supplementation on exercise performance, 
Spector et al. (14) conducted a randomized, double-blind, crossover study with 20 highly 
trained male cyclists with ages between 21 and 29. The subjects consumed a 200 mL 
fruit drink containing 6% glucose solution, 70 mg sodium, 25 mg potassium, and B 
vitamin complex with or without 2.43 g of choline bitartrate, twice before performing 
exercise tests wherein one group of subjects (n=10) cycled at 150% of their VO2max 
until exhaustion, and the other group (n=10) performed a prolonged cycling at 70% of 
VO2max until exhaustion. The choline supplement induced 37% and 52% increase in 
blood choline concentration in both groups within one hour of ingestion, and the 
increased blood choline levels were maintained throughout the exercise and until 45 
minutes after exercise. On the other hand, blood choline levels were maintained between 
8.0 and 11.5 µM and did not drop with the placebo treatment. The results showed no 
effect of pre-exercise choline ingestion on exercise performance at either 
intensity/duration of cycling exercises. There was no difference between choline and 
placebo treatments in performance measures such as heart rates, ventilation, oxygen 
uptake, carbon dioxide production, respiratory exchange ratio, time to exhaustion, and 
total work output (14). The results suggest that pre-exercise choline ingestion as well as 
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the resultant increase in blood choline concentration may not modify exercise 
performance in trained cyclists. 
The effect of choline supplementation was also examined in marathon runners. 
Buchman et al. (17) randomly assigned 12 established marathon runners (21 to 50 years 
old, 7 males and 5 females) into either lecithin supplement group or placebo group. The 
lecithin group consumed approximately 2.2 g of choline over two days (one day prior to 
and on the marathon day). The plasma free choline levels were increased by 46% post-
race compared with baseline values (from 8.0 ± 1.2 µM to 11.7 ± 2.5 µM) in the 
supplement group, while there was 26% decline in placebo group (from 9.6 ± 2.5 µM to 
7.0 ± 3.6 µM). However, the mean finish time of lecithin group was 256.3 ± 46.3 
minutes, and that of placebo group was 240.8 ± 62 minutes, suggesting there was no 
effect of choline ingestion and blood choline levels on exercise performance in marathon 
runners (17).  
Warber et al. (15) also examined the effects of choline supplementation on 
exercise performance in 14 young male soldiers. The soldiers consumed either placebo 
or choline drinks before and during a 20 km load carriage walk exercise on a treadmill at 
the speed of 5.6 km/h in the double-blind crossover study. After the walk exercise, they 
also participated in a run-to exhaustion test as well as a squat-to failure test with 45.5 kg 
barbell at the rate of 25 repetitions per minute. Even though 6 g of choline 
supplementation before and during the 4 hour exercises resulted in 128% increase in 
blood choline concentration at the end of the tests compared with the beginning of the 
tests, there was no difference in oxygen uptake, heart rate, rating of perceived exertion 
28 
(RPE), time-to-exhaustion, or number of repetitions to failure between placebo and 
choline treatments. Deuster et al. (16) also examined the effect of choline 
supplementation on physical and cognitive performances following military style load 
carriage and no-load carriage treadmill exercises. The results showed that choline 
administration (50 mg/kg) increased plasma choline levels of the subjects but did not 
improve physical and mental performances (16). 
Also, in a study conducted by Hoffman et al. (18), healthy college students 
performed a 4 minute reaction test, a 30-second Wingate Anaerobic Power test, 
maximum push-ups for one minute, and maximum sit-ups for one minute, followed by 
another bout of the same 4-minute reaction test, after consuming either placebo or 
supplement composed with α-glycerophosphocholine (150 mg), choline bitartrate (125 
mg), phosphatidylserine (50 mg), vitamins B3 (30 mg), B6 (30 mg), and B12 (0.06 mg), 
folic acid (4 mg), L-tyrosin (500 mg), anhydrous caffeine (60 mg), acetyl-L-carnitine 
(500 mg), and naringin (20 mg). The acute consumption of the choline supplement 
combined with caffeine, carnitine, and other nutrients did not have any effect on 
muscular endurance or power performance, compared with placebo. The supplement 
only had a positive effect on maintaining reaction time following the acute bout of high 
intensity exercise session (the supplement alleviated exercise induced decline of reaction 
time), but it is unclear which ingredient(s) of the supplement mix induced the effect. The 
authors speculated that the ingredients in the supplement may have had neuro-protective 
effects through strengthened membrane integrity. Additionally, to determine if there is 
any effect of prolonged supplementation, the subjects repeated the same tests after 
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consuming either placebo or supplement for 4 weeks, but the results were very similar to 
the acute consumption tests (no effect on power and muscular endurance as well as 
reaction time) (18). 
Summary of Exercise and Choline Studies: Unanswered Questions Still Remain 
As discussed so far, it seems that some exercises can lower blood choline levels 
but most other exercises do not have any effects on blood choline concentrations. Only 
those exercises that are very long in duration and very strenuous in intensity at the same 
time seem to be able to lower blood choline levels. However, the effect of low blood 
choline levels (either through diet or exercise) on exercise performance has been 
understudied and is currently unclear. Likewise, the effects of choline consumption to 
prevent drop in blood choline concentration or restore normal blood levels of choline on 
exercise performance are also unknown. 
The current body of literature shows that there is little to no effect of choline 
supplementation on exercise performance when the exercise does not lower blood 
choline levels. It appears that choline does not have meaningful effects on exercise 
performance in general, if one can maintain normal range of blood choline concentration 
(through either diet or exercise). Data also indicate that higher choline intake increases 
blood levels of choline, but increased choline consumption (higher than potential 
threshold levels) and resultant higher blood choline concentration may not provide 
additional benefits on exercise performance. However, since many of these studies used 
mostly acute aerobic/endurance type of exercise models at low to moderate intensities, 
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the relationship between choline intake and resistance exercise/training is largely 
unknown. Moreover, these studies mostly examined the effect of acute consumption of a 
large amount of choline supplements with lack of nutritional control in many cases, 
leaving the effects of chronic/habitual consumption of (lower) choline, which may limit 
the optimal muscle responses to RET, unexamined and unknown.  
There is evidence suggesting that neuromuscular transmission failure plays a 
significant role in fatigue of skeletal muscles composed with predominantly fast-twitch 
fibers (63). Unlike aerobic/endurance exercises, high intensity RE mostly stimulates and 
utilizes fast-twitch fibers. Therefore, if ACh availability mediated by choline intake 
plays a role in neuromuscular transmission failure, it may be possible to observe 
different effects of choline on exercise performance and muscle responses to RE. While 
endurance exercise, due to its low frequency nerve firing nature, allowing nerve fibers 
enough opportunity to re-synthesize ACh, may not affect ACh levels at NMJ, RE may 
limit the ACh availability and influence neural activation, muscle contraction, and force 
generation, due to its high frequency nerve firing pattern, the ability to recruit greater 
number of motor units, and usage of larger muscle masses utilizing more ACh. Data also 
suggest that blood choline is regulated at relatively constant levels even with prolonged 
period of moderately low choline consumption, and blood concentration of choline does 
not reflect intracellular levels of choline effectively (38, 64), because our bodies can 
synthesize a certain amount of choline in the liver, and choline can be provided by 
degradation of PC. There might be situations where low choline intake affects muscle 
responses through subtly limiting ACh synthesis and release, preventing optimal muscle 
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action/response to RE (through impaired neuromuscular transmission) while maintaining 
blood choline concentration at relatively stable levels. 
As discussed earlier, myocytes incubated in choline deficient medium are more 
prone to mechanical stress due to compromised membrane integrity (6). This may be 
another potential mechanism by which low choline intake can affect exercise 
performance and muscle responses to RE, which imposes greater mechanical stress/load 
on muscle cells than endurance exercise does. The lack of sufficient choline and PC may 
result in structurally weak cell membranes, and limit the muscle’s ability to withstand 
mechanical stress of exercises and to produce forces, compromising exercise 
performance. Also, choline deficiency may affect optimal supply of PC for enlarging 
muscle cells and membranes in response to RET, limiting hypertrophy and associated 
strength gains. 
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CHAPTER III 
LOWER INTAKE OF CHOLINE IS ASSOCIATED WITH DIMINISHED 
STRENGTH AND LEAN MASS GAINS FOLLOWING 12 WEEKS OF 
RESISTANCE TRAINING IN 60-69 YEAR OLD MEN AND WOMEN 
Introduction 
Skeletal muscle constitutes ~50% of total body mass and is responsible for more 
than half of the whole body metabolism (65). It is also the largest reservoir of glycogen 
and amino acids, and skeletal muscle dysfunction is related to many important health 
issues including cardiovascular diseases, diabetes, obesity, and osteoporosis. In addition, 
after the age of 40, skeletal muscle mass and strength is steadily lost by as much as five 
percent per decade in a condition referred to as ‘sarcopenia’ (66, 67). Therefore, 
optimizing skeletal muscle mass and function has utmost importance considering the 
effects of skeletal muscle on overall health and well-being. 
It is well known that resistance exercise (RE) has a significant impact on 
increasing/maintaining muscle mass and the associated strength/function. It is also well 
established that the effects of RE can be, at least in part, moderated by nutritional intake. 
However, besides total energy intake, carbohydrate, and protein, the effects/roles of 
other macro/micronutrients on the muscle responses to RE are still unclear (3). 
Choline plays important roles in human physiology including cell membrane 
integrity/signaling, lipid transport, and methylation. Because choline deficiency (<10% 
of Adequate Intake [AI]) is associated with muscle damage, steatosis, organ dysfunction, 
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and neurological disorders, choline was officially acknowledged as an essential 
micronutrient by the Institute of Medicine (IOM) in 1998 (19, 29), but little data on 
choline content of foods were available until 2004 (43). Choline is also a precursor to 
acetylcholine (ACh), a neurotransmitter which relays a signal between motor neurons 
and skeletal muscles to generate force. Therefore, it is reasonable to hypothesize that 
choline intake may be associated with exercise performance and skeletal muscle 
responses to exercise. 
There have been a few studies that examined the relationship between choline 
and exercise performance in various circumstances. Several studies reported that 
marathon runs or high speed bicycle rides for long duration resulted in decreased blood 
choline concentrations, but the effect of lowered blood choline levels on exercise 
performance was equivocal (11-13). Other studies reported treadmill exercises, cycling, 
and cross country races had no effect on blood choline, and choline supplementation to 
maintain or increase blood choline concentrations did not affect exercise performance 
(13-17). 
However, these studies were conducted in the context of acute bouts of 
aerobic/endurance exercises, and there has been no study that examined the effect of 
choline intakes on skeletal muscle mass and strength responses to resistance exercise 
training (RET). Considering ACh synthesis is proportional to neural activation rate, and 
endurance exercise has a relatively low frequency activation rate, it is not surprising that 
choline effects are equivocal with endurance exercise. Moreover, many of the previous 
studies lacked nutritional control in general and specifically for choline due to dearth of 
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information on choline content of foods, which may have further obscured potential 
effects of choline on muscle responses to exercise. 
The purpose of this study was to examine the relationship between variability of 
choline intake in the context of a “healthy diet”, as recommended by the American 
Dietetic Association (ADA, now known as the Academy of Nutrition and Dietetics), and 
muscle responses to a standard RET program in older adults. We hypothesized that 
variability of choline intake would be linearly associated with the magnitude of strength 
and lean mass gains following 12 weeks of RET. 
Methods 
Participants 
Forty-six, 60-69 year old men and women (males: 64.3 ± 3y; females: 63.7 ± 3y, 
postmenopausal for more than 2 years), recruited through advertisements, flyers, and 
mailings to local community and senior centers, completed a 12-week RET program 
designed to increase lean mass and muscular strength. All the participants were non-
smokers, generally healthy, and untrained: Individuals with uncontrolled high blood 
pressure (>160/100 mmHg), diabetes, cardiac arrhythmias, cancer, hernia, aortic 
aneurysm, kidney disease, and/or lung disease were excluded, and those who engaged in 
more than one hour of RET per week on average in the previous 12 months were not 
eligible for the study. This study was approved by the Kent State University and Texas 
A&M University Institutional Review Boards, and all the participants provided written 
informed consent. Other details on this cohort are provided elsewhere (68, 69). 
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Pre-Study Orientation 
Before starting the 12-week RET program, participants attended six orientation 
sessions over two weeks. Each orientation session comprised one hour of exercise 
familiarization, wherein the participants learned correct exercise techniques by 
exercising at low intensity (40% of their estimated maximum strength based on the 
Omnibus-RE Scale [OMNI-RES] ratings of perceived exertion [RPE]) (70) to reduce the 
possibility of injury and standardize early gains in strength by motor learning, and 30 
minutes of nutrition education by a registered dietitian on proper nutrient intake and 
accurate diet log documentation. Participants were instructed to maintain isocaloric food 
intake (50% carbohydrate, 30% fat, 20% protein, and <10% saturated fat) and consume 
>1.0 g/kg/d of protein, 25-30 g/d of fiber, and <300 mg/d of cholesterol, as 
recommended by the ADA, throughout the study. 
Testing 
Upon completion of the orientation and at least 72 hours before the first RET 
session, body composition was measured by dual energy X-ray absorptiometry (DEXA) 
using Hologic 4500 QDR (Bedford, MA), and maximum strength (1RM) for all the 
exercises included in the RET program was determined using the following protocol 
(70): After a three-minute warm-up on cycle ergometers (Schwinn Fitness, Inc., Denver, 
CO) and dynamic full body stretching, participants performed four warm-up repetitions 
with a resistance set at 55% of investigator/participant estimated 1RM based on OMNI-
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RES RPE. The resistance was then adjusted to 75% of re-estimated 1RM, and 
participants performed one repetition. The resistance was increased again to 90% of re-
estimated 1RM for participants to perform one repetition. The attempts for true 1RM 
were made by gradually increasing resistance in a manner that the total number of 1RM 
attempts was minimized (70). The exercise order for 1RM measurement was the same 
for all participants, and the rest interval between each attempt was 60 seconds. The same 
testing was repeated at the completion of the 12-week program to determine RET 
responses. 1RM and body composition tests were performed 48 hours and 72 hours after 
the last RET session, respectively. 
Resistance Exercise Training 
For 12 weeks, participants performed whole body RET three times per week (on 
non-consecutive days) using Cybex RET machines (Cybex International Inc., Medway, 
MA). The exercises comprised chest press, lat pull down, leg press, knee extension, 
seated leg curl, triceps extension, biceps curl, and calf raises. On each exercise day, the 
participants performed a 10-minute warm-up on the Schwinn cycle ergometers, five 
minutes of stretching, and three sets of 8-12 repetitions of the eight exercises. Resistance 
was set at 75% of each participant’s 1RM, and the participants performed as many 
repetitions as possible until they reached 12 repetitions or muscle failure (inability to 
complete a repetition with proper form and full range of motion). When a participant 
achieved 12 repetitions on all three sets of an exercise, the exercise weight was increased 
so that the participant would only be able to achieve eight repetitions per set in the next 
37 
session. This is to ensure that relative exercise intensity (75% of 1RM) was maintained 
throughout the study as participants gained strength. All the exercise sessions were 
monitored by research assistants, and the rest time was 60 seconds between sets and two 
minutes between exercises. The participants were instructed to maintain their non-RET 
physical activities at current levels but not to perform additional RET outside of the 
study. 
Nutrition 
The participants were required to maintain and submit diet logs three times per 
week on non-consecutive days to investigators for the entire duration of the study. 
Feedback on the diet logs were provided weekly to ensure compliance to the diet 
recommendations. To help ensure enough protein consumption for muscle gain and to 
minimize potential effects of variable protein intake, participants consumed post-
workout supplements (Boost High Protein; Nestle S.A., Vevey, Switzerland) 
immediately after each exercise session. The amount of the supplement was adjusted to 
each participant’s lean mass so that 0.4 g of protein/kg of lean mass was consumed with 
each supplement. 
The average intake values of all macro/micro nutrients during the 12-week 
intervention were calculated using the diet logs entered into Nutribase software (version 
5; Cybersoft Inc., Phoenix, AZ) and the USDA database for choline (44). Then 
participants’ mean choline intakes during the 12 weeks were categorized into three 
groups (Low: <5.6 mg/kg lean mass/day, Med-Low: 5.6-8.0 mg/kg lean/d, and 
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Adequate: >8.0 mg/kg lean/d) based on the data distribution (median and natural 
breakpoints). 
Statistical Analysis 
All statistical analyses were conducted using IBM SPSS Statistics software 
(version 21; IBM Corporation, Armonk, NY). The assumption of normal distribution 
was checked using Shapiro-Wilk test, and non-normal variables were log or square root 
transformed before tested with parametric statistical procedures. Non-parametric tests 
were also conducted with non-transformed data to demonstrate consistency of the test 
results. 
Student’s independent t-tests were performed to examine differences between 
two groups (e.g., men and women), and paired t-tests were used to compare pre- and 
post-training values. Pearson’s correlations were used to examine associations between 
nutrient intakes and RET responses, and linear regression analyses were performed to 
examine the independent association of choline consumption with changes in composite 
strength and lean mass. Composite strength was defined as chest press 1RM + leg press 
1RM, and percent change was calculated as 100 x (post training measurement - pre 
training measurement) / pre training measurement. 
The differences in RET responses between choline intake groups were examined 
using one-way analysis of variance (ANOVA). A two-way ANOVA was performed to 
determine if there were differences in RET responses between choline groups or gender, 
and analysis of covariance (ANCOVA) tests were used to account for the effects of 
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potential confounders (other nutrients, age, etc.). The assumption of equal variance was 
checked using Levene’s test, and the Bonferroni method was used to perform multiple 
comparisons. P values of <0.05 were considered statistically significant, and data are 
presented as mean ± standard deviation (SD) unless stated otherwise. 
Results 
Participants 
The baseline characteristics of the 46 participants who completed the study are 
presented in Table 3. There was no significant difference between choline intake groups 
in age, body weight, body fat, or BMI, but there were more male participants in the Low 
choline group, of which participants had greater baseline lean mass compared with the 
other groups. 
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Table 3. Participant’s Baseline Characteristics 
Low (n=20) Med-Low (n=19) Adequate (n=7) 
Age (years)  65.0 ± 3.2  63.3 ± 3.0   63.0 ± 2.5
Male/Female 16/4 3/16† 0/7†
Height (inches)  68.2 ± 3.9  65.3 ± 3.6 63.6 ± 2.4*
Weight (kg) 84.2 ± 16.4 78.7 ± 11.9  71.9 ± 16.0
Body fat (kg) 24.4 ± 7.7 29.5 ± 8.0 28.6 ± 11.2
Lean mass (kg)  58.2 ± 10.9 47.3 ± 8.4†  42.0 ± 5.5†
BMI (kg·m
-2
) 27.9 ± 3.5 28.6 ± 4.0 27.7 ± 6.9
Data are presented as mean ± SD. Low: choline intakes of 2.9-5.5 mg/kg lean/d. Med-Low: 
choline intakes of 5.6-8.0 mg/kg lean/d. Adequate: choline intakes of 8.1-10.6 mg/kg lean/d. 
* denotes a significant difference from Low group (p<0.05). † denotes a significant difference
from Low group (p<0.01). 
Nutritional Intakes 
All the participants met dietary recommendations for caloric intake, protein 
consumption, cholesterol intake, and proportions of macronutrients, and there was no 
difference between choline groups in these nutrient intakes except for protein/kg (higher 
in Adequate group) and percent of kcal from carbohydrate (lower in Med-Low group) 
(Table 4). No significant differences were observed in intakes of micronutrients related 
to choline metabolism such as vitamins B5, B6, B12, folate, and betaine (data not shown). 
The average choline consumption during the study period was 304.2 ± 70 mg/day 
(6.1 ± 1.6 mg/day and 3.9 ± 0.9 mg/day when adjusted for kg lean mass and kg body 
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weight, respectively), which is consistent with previously reported choline intake data 
(313 mg/d in the Framingham Offspring Study, 335 mg/d in NHANES 2011-2012; 372 
mg/d in men and 304 mg/d in women in Yonemori et al.’s study) (22, 45, 48). Dietary 
choline (mg/kg lean/d) was correlated with kcal/kg lean/d (r=0.516, p<0.001), protein 
intake (g/kg lean/d, r=0.733, p<0.001), carbohydrate intake (g/kg lean/d, r=0.295, 
p=0.047), fat intake (g/kg lean/d, r=0.442, p=0.002), and dietary cholesterol (mg/kg 
lean/d, r=0.519, p<0.001), but none of these nutrients were significantly correlated with 
muscle responses to RET except for dietary cholesterol which was significantly 
correlated with percent changes in composite strength (r=0.386, p=0.009) and lean mass 
(r=0.364, p=0.013). 
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Table 4. Nutritional Intakes 
Low (n=20) Med-Low (n=19)  Adequate (n=7) 
Total Energy (kcal/kg/d) 23.0 ± 4.7 21.7 ± 6.3 26.7 ± 6.4 
Protein (g/kg/d) 0.9 ± 0.1 1.0 ± 0.2  1.2 ± 0.2‡ 
Carbohydrate (g/kg/d) 2.7 ± 0.8 2.3 ± 0.8 2.9 ± 0.9 
Fat (g/kg/d) 0.7 ± 0.2 0.8 ± 0.3 0.9 ± 0.3 
% of total kcal from carbohydrate 53.8 ± 8.0  48.0 ± 6.7* 49.0 ± 6.3 
% of total kcal from protein  16.0 ± 2.2 18.1 ± 3.8 18.1 ± 4.7 
% of total kcal from fat 28.6 ± 6.5 32.4 ± 6.1 30.7 ± 5.8 
Cholesterol (mg/kg/d) 2.5 ± 1.0 3.0 ± 1.0 3.4 ± 1.0 
Data are presented as mean ± SD. Low: choline intakes of 2.9-5.5 mg/kg lean/d. Med-Low: 
choline intakes of 5.6-8.0 mg/kg lean/d. Adequate: choline intakes of 8.1-10.6 mg/kg lean/d. 
* denotes a significant difference from Low group (p<0.05). ‡ denotes a significant difference
from the other groups (p<0.05). 
Effects of Choline on RET Responses 
Choline intake (mg/kg lean/d) was significantly correlated with percent change in 
composite strength with medium effect size (r=0.36, p=0.015), and a simple regression 
analysis indicated that there was a significant linear relationship where choline intake 
(mg/kg lean/d) predicts percent change in composite strength (β=0.655, t=2.534, 
R2=0.13, p=0.015), while a trend was observed between choline consumption (mg/kg 
lean/d) and percent change in lean mass (r=0.265, p=0.075). 
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Also, there was a significant difference in composite strength gains between 
choline groups (Figure 4). While RET resulted in significant increases in lean mass and 
strength in all three groups (Table 5 and 6), the Low choline group gained significantly 
less composite strength compared with the other groups (Low: 30.9 ± 15.1%, Med-Low: 
70.3 ± 48.5%, Adequate: 81.9 ± 68.4%; p=0.004). The Low choline group also showed 
significantly reduced changes in 1RM for leg press and chest press compared with the 
higher choline intake groups (Table 6), and similar trends were observed for calf raises 
(p=0.08) and triceps extension exercises (p=0.07). Additionally, non-parametric tests 
(Spearman’s Rho and Kruskal-Wallis test) showed the same results (data not shown) that 
are consistent with Pearson’s correlation and ANOVA tests, confirming the strong 
association between choline intake and composite strength gain. 
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Figure 4. The Effect of Choline Intake on Changes in Composite Strength 
Data are presented as mean ± standard error (SE). Composite strength is defined as chest 
press 1RM + leg press 1RM. * denotes a significant difference from Low group 
(p<0.01).  
Table 5. The Effect of Choline Intakes on Body Composition 
Low (n=20) Med-Low (n=19)  Adequate (n=7) P values 
Change in lean mass (kg) 0.9 ± 1.7 1.4 ± 1.7 1.5 ± 0.6 0.50 
Percent change in lean mass 1.5 ± 2.8 2.9 ± 3.3  3.7 ± 1.8 0.15 
Change in body fat (kg) -1.9 ± 1.6 -1.6 ± 2.1 -1.5 ± 2.1 0.88 
Percent change in body fat -7.5 ± 6.6 -4.8 ± 5.8 -5.5 ± 5.8 0.40 
Data are presented as mean ± SD. Low: choline intakes of 2.9-5.5 mg/kg lean/d. Med-Low: 
choline intakes of 5.6-8.0 mg/kg lean/d. Adequate: choline intakes of 8.1-10.6 mg/kg lean/d. All 
changes from baseline are statistically significant except for change in body fat (kg) in Adequate 
group. No differences were observed between choline intake groups (p>0.1). 
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Table 6. The Effect of Choline Intakes on Changes (%) in 1RM 
Low (n=20) Med-Low (n=19)  Adequate (n=7) 
Leg Press 35.7 ± 19.7 77.4 ± 50.6* 97.5 ± 87.1* 
Chest Press 19.4 ± 10.5 50.9 ± 50.2*  42.7 ± 29.3 
Lat Pull Down 36.5 ± 26.5 44.4 ± 33.0 49.4 ± 36.8 
Knee Extension 42.6 ± 27.7 56.0 ± 47.0 61.9 ± 71.0 
Leg Curls 30.8 ± 24.3 47.5 ± 35.4 18.2 ± 26.0 
Calf Raises 74.1 ± 40.3 102.7 ± 77.8 156.1 ± 92.9 
Triceps Extension 29.4 ± 17.3 36.7 ± 18.2 48.7 ± 24.8 
Biceps Curls 31.0 ± 22.6  53.8 ± 45.7 39.6 ± 24.6 
Data are presented as mean ± SD. Low: choline intakes of 2.9-5.5 mg/kg lean/d. Med-Low: 
choline intakes of 5.6-8.0 mg/kg lean/d. Adequate: choline intakes of 8.1-10.6 mg/kg lean/d. All 
changes from baseline are statistically significant. * denotes a significant difference from Low 
group (p<0.05). 
Since there was a difference between choline groups in gender distribution, and 
women had higher intakes of protein (g/kg lean/d), cholesterol (mg/kg lean/d), and 
choline (mg/kg lean/d), a two-way ANOVA test was conducted to determine if there was 
a difference in composite strength gains (%) between choline groups or gender. There 
was no gender x choline group interaction, and the effect of gender was not significant 
while the main effect for choline intake was statistically significant (p<0.05). Multiple 
comparisons showed the Low group gained significantly less composite strength 
compared with the other groups (p<0.05). 
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Choline consumption was correlated with total energy, protein, carbohydrate, fat, 
and cholesterol intakes in the present study. Since many choline rich foods (e.g., eggs, 
fish, and meat) are also rich in fat, protein, and cholesterol (44), and choline metabolism 
is intertwined with betaine, folate, and vitamins B5, B6, B12 metabolism (29, 37), 
ANCOVA tests were conducted to separate the effects of these dietary factors as well as 
other covariates such as age and baseline lean mass from the effects of choline. 
Significant (p<0.05) differences in composite strength gains (%) between choline groups 
were observed in the presence of these covariates, separately or in various combinations 
(data not shown), indicating independent effects of choline intake on strength gains. 
Multiple linear regression analyses were also conducted to further separate the 
effects of choline from those of other variables such as age, gender, and other nutrients, 
especially cholesterol, because cholesterol was previously reported to be associated with 
strength and lean mass in older adults (69) and was correlated with RET responses in the 
present study. All of the aforementioned variables were initially entered into the 
equation, and after a series of backward elimination procedures, only low choline intake, 
age, and cholesterol intake remained in the final model, which showed that choline 
intake independently predicts percent change in composite strength (adjusted R2=0.268, 
p=0.001) (Table 7). 
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Table 7. Multiple Regression Analysis of the Independent Effect of Choline Consumption, 
Dietary Cholesterol, and Age on Change in Composite Strength (%) Following 12 Weeks of 
RET 
Unstandardized Coefficients 
Predictors β SE  P values 
(Constant) 13.135 4.149 0.003
Low Choline Intake -1.833 0.847  0.036
Age (years) -0.002 0.001 0.089
Cholesterol Intake (mg/kg lean/d) 0.341 0.236 0.156
SE: standard error. Low Choline Intake: 2.9-5.5 mg/kg lean/d. 
Because RET responses, nutritional intakes, and demographic characteristics 
were similar between Med-Low and Adequate groups (Tables 3-5, Figure 4), the two 
groups were pooled for further analyses. ANCOVA tests showed that the Low group 
gained significantly diminished lean mass compared with the higher choline intake (5.6-
10.6 mg/kg lean/d) group (1.3 ± 0.6% vs. 3.2 ± 0.6%; folate/kg lean/d as a covariate; 
estimated marginal mean ± standard error [SE], p<0.05). Two-way ANOVA test showed 
a trend (p=0.076) indicating the effect of choline intake on percent change in lean mass, 
while gender and choline intake x gender interaction were not statistically significant 
(p>0.5). Non-parametric independent-samples Mann-Whitney U test also indicated that 
the distribution of percent change in lean mass was significantly different between the 
two choline intake groups (p<0.05).    
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Discussion 
The purpose of this study was to examine the relationship between habitual, 
food-based choline intake and changes in strength and lean mass following 12 weeks of 
RET. To our knowledge, the present study is the first to examine the effect of habitual 
choline intake on muscle responses to RET in older adults. The major finding of the 
present study was that choline intake is strongly associated with the magnitude of 
strength gains following 12 weeks of RET in older adults. Our data also indicated a 
moderate effect of choline intake on lean mass gains. 
The mechanism through which choline may affect strength and lean mass gains 
with RET is unknown, however, there exist a few potential mechanisms. Choline is a 
precursor to ACh, the main neurotransmitter in α-motor neurons, and evidence shows 
ACh production and release can be mediated by availability of choline (4, 5). Therefore, 
dietary choline may affect availability of ACh at the neuromuscular junctions (NMJ), 
influencing muscle contraction and force production in skeletal muscles. While previous 
studies utilizing endurance exercise models failed to observe meaningful effects of 
choline, dietary choline might have different effects on ACh in the context of RE. 
Neuromuscular transmission failure is suggested as a major factor in fatigue of 
skeletal muscles predominantly composed of fast-twitch fibers (63), which are recruited 
mostly with RE. If ACh availability plays a key role in neuromuscular transmission 
failure (71, 72), dietary choline may differentially affect exercise performance with RE. 
The low frequency motor output and lower number of active motor units associated with 
endurance exercise might allow sufficient re-synthesis of ACh in motor neurons while 
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high frequency motor output and greater number of motor units recruited with RE might 
reduce ACh availability at the NMJ. 
Choline is also a precursor to phosphatidylcholine (PC), which is the most 
abundant phospholipid in all cellular membranes, and choline deficiency has been shown 
to induce weakened cell membranes and muscle damage (6). Structurally weak cell 
membranes may negatively influence muscle’s ability to handle mechanical load, which 
is greater with RE, and an increase in lean mass as a result of RET may require more PC 
as a substrate for enlarging muscle cells and membranes. In addition, PC is a precursor 
to phosphatidic acid (PA), which is required to activate mammalian target of rapamycin 
(mTOR), a central element in regulation of protein synthesis (26). Choline also plays an 
important role in methylation reactions, crucial steps for control of gene expression, 
protein synthesis, and other metabolic pathways (10, 28). Therefore, insufficient choline 
consumption might limit skeletal muscle hypertrophy and strength gains associated with 
RET through several physiological processes. 
We also observed that the majority of the subjects in the present study consumed 
less than the recommended amount of choline (90th percentile of choline intake was 393 
mg/d), which is similar to previously published data (only 20% of the subjects [mean 
age:54y] consumed >401 mg/d choline in the Framingham Offspring Study, and 80% of 
1,477 women [mean age: 52y] consumed less than 361 mg of choline per day in Chiuve 
et al.’s study) (47, 48), providing additional evidence showing that inadequate choline 
consumption is prevalent, at least in older populations. The current AI of choline for 
adults is ~7 mg/kg/d (550 mg/d for males and 425 mg/d for females) (19). 
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In the present study, the Low, Med-Low, and Adequate groups consumed 
approximately ~49%, ~63%, and ~85% AI of choline, respectively. We observed that 
the Low group (< ½ of AI) gained significantly less strength and lean mass following 12 
weeks of RET compared with higher choline intake groups. Reduced strength gains with 
inadequate choline intake reported presently adds to the established list of consequences 
identified with extremely low choline consumption (<10% AI) including muscle/liver 
damage, cardiovascular disease, fatty liver, neurological disorder, and cancer. These 
results suggest that even normal/average intakes, which are below AI but do not present 
overt clinical signs, may still have consequences that affect health and well-being of 
older adults. Since the results of the present study provide evidence only in the low to 
near adequate levels of choline consumption, the effects of higher choline intake on lean 
mass and strength gains still remain unknown. Even though previous studies did not 
observe any effect of choline supplementation (higher than AI) on endurance exercise 
performance, higher choline consumption might influence muscle responses to RET 
differently. 
It should be noted that there are several limitations to our study. We were not 
able to determine blood choline concentrations, therefore the associations of blood 
choline with muscle responses to RET were not examined. However, we believe this 
does not change the overall conclusions of our observation because blood choline levels 
do not effectively reflect moderate changes in choline intake (64). Data also suggest that 
blood choline is regulated at relatively constant levels with moderately low choline 
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consumption in resting individuals, and blood concentration of choline does not 
represent intracellular levels of choline (38, 64, 73). 
Also, the well-known limitations of dietary records may have affected the 
accuracy of our analyses. However, the impact of potentially inaccurate diet records was 
minimized by combined effects of pre-study nutrition education, collection of weekly 
diet report for 12 weeks (>36 records per subject), and provision of regular feedback to 
encourage compliance to the diet guidelines and accurate documentation of food intake. 
In addition, there was a significant difference in gender distribution between 
choline groups in the present study (Table 3), which may have confounded the results of 
our analyses. However, extensive efforts to separate the influence of gender as well as 
other potential confounders from that of dietary choline using various statistical 
techniques including two-way ANOVA, ANCOVA, and multiple regression tests, 
consistently indicated that the significant effects of choline intake observed presently 
was independent of gender and/or other confounders. Moreover, studies suggest that 
physiological responses to different amounts of choline intake are similar between men 
and postmenopausal women (38), and skeletal muscle responses to RET are not different 
between genders, at least in older adults (74, 75), supporting the conclusion of the 
present study. 
Summary 
Our data suggest that dietary choline has a linear relation (in the 49th-85th 
percentile of AI) with skeletal muscle responses to 12 weeks of RET in generally healthy 
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60-69 year old men and women. Lower intake of choline was associated with reduced 
gains in strength and lean mass in this population. The potential mechanisms of these 
effects of dietary choline may include ACh availability at the NMJ, membrane integrity, 
cell signaling, and/or methylation reactions. Considering the effects of skeletal muscle to 
overall health and well-being, especially in older population whose choline intake is 
persistently low, it is important to optimize nutritional factors to maximize the benefits 
of RET. Future studies are warranted to confirm the results of the present study and 
elucidate the mechanism through which choline affects skeletal muscle responses to 
RET. 
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CHAPTER IV 
THE EFFECTS OF CHOLINE SUPPLEMENTATION AND RESISTANCE 
TRAINING ON STRENGTH AND LEAN MASS GAINS IN OLDER ADULTS: 
A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL TRIAL 
Introduction 
Choline plays crucial roles in several physiological processes such as 
neurotransmission and muscle contraction via synthesis of acetylcholine (ACh), lipid 
transport via lipoprotein synthesis, and methyl-group metabolism as a precursor to 
betaine. It also supports cell membrane integrity/function as a precursor to 
phosphatidylcholine (PC), the most abundant phospholipid in all cellular membranes. 
Choline can be obtained from the diet (exogenously) or from de novo PC 
synthesis (endogenously) through sequential methylations of phosphatidylethanolamine 
(PE) (24). However, the amount of choline produced via de novo synthesis is not 
sufficient to support total choline requirement. Therefore, the majority of the required 
choline must be acquired from diet (19), and choline deficient diet (<10% of Adequate 
Intake [AI]) has been associated with negative health conditions including liver/muscle 
damage, nonalcoholic fatty liver disease, atherosclerosis, birth defects (neural tube 
defects), and neurological disorders (29). 
We have observed that lower intake of choline was associated with reduced 
strength and lean mass gains following 12 weeks of resistance exercise training (RET) in 
60-69 year old individuals (76), providing additional evidence that sufficient choline 
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intake is important for older individuals’ health and well-being. In that study, subjects’ 
habitual, food based choline consumption ranged between 49% and 85% of AI, and a 
linear relation was observed between choline intake and percent change in strength 
(between 31% and 82%) within that range, suggesting lower choline intake may 
negatively affect muscle responses to RET (76). However, it is still unclear whether 
higher choline intake (≥AI) positively affects strength and lean mass gains with RET. 
Previous studies regarding choline supplementation and exercise generally 
reported that consumption of choline exceeding AI, sufficient to increase blood levels of 
choline, does not positively affect exercise performance. Spector et al. (14) reported that 
choline supplementation of ~970 mg (~200% of AI) prior to cycling did not affect heart 
rate, ventilation, oxygen consumption, time to exhaustion, and total work output in 
young athletes. Similarly, 6 g of choline supplementation (11 times AI) before and 
during four hours of treadmill walk, run-to-exhaustion, and squat-to-failure tests did not 
affect oxygen uptake, heart rate, or time to exhaustion in young male soldiers (15). Other 
studies also reported no effect of pre-exercise choline supplementation (greater than AI 
values) on exercise performance with military style load-carriage test, a marathon run, or 
Wingate/push-up/sit-up tests (16-18). However, these studies lacked nutritional control 
of habitual choline intake and only examined the acute effects of choline 
supplementation on endurance performance variables, leaving the effects of choline 
supplementation greater than AI on resistance exercise (RE) and training responses 
largely unknown. 
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The purpose of the present study was to determine the effects of various amounts 
of choline intakes (including higher than AI) on muscle responses to RET. We 
supplemented subjects’ habitual choline intake from a standard healthy diet, as 
recommended by the American Dietetic Association (ADA, now known as the Academy 
of Nutrition and Dietetics), with choline in the form of egg yolk and examined the 
effects of dietary choline on changes in strength, lean mass, muscle quality, clinical 
markers of muscle/liver damage, and blood lipids in older men and women following 12 
weeks of RET, with a randomized double-blind placebo-controlled study design. 
Methods 
Participants 
Thirty-seven, 50 to 69 year old, generally healthy men and women were recruited 
via flyers and advertisements in a local newspaper. Smokers and individuals with any of 
the following health conditions were excluded: hypertension (> 160/100 mmHg), cardiac 
arrhythmias, cancer, hernia, aortic aneurysm, kidney disease, diabetes, lung disease, 
blood cholesterol >240 mg/dl or <160 mg/dl, or taking cholesterol lowering medications. 
Those who participated in one hour or more of RET in the previous year were not 
eligible for participation, and women needed to be postmenopausal for more than two 
years. The eligible subjects were randomly assigned into one of three choline groups in a 
double-blind manner: zero additional egg yolk (Low), one additional egg yolk (Med), or 
three additional egg yolks (High) per day. This study was approved by Texas A&M 
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University Institutional Review Board, and all the participants provided written informed 
consent prior to participation in the study. 
Orientation 
During two weeks of a pre-study orientation period, the participants attended two 
sessions of nutrition education by a registered dietitian (RD) and four sessions of 
exercise orientation/familiarization. Each nutrition education session lasted for two 
hours, and the participants learned about proper nutrient intake, calorie/portion control, 
and study specific diet guidelines. They also practiced the use of a nutrition software 
(Nutribase; version 7;  Client Intake Module; Cybersoft Inc., Phoenix, AZ) with which 
they maintained diet logs throughout the study. The exercise orientation provided the 
participants with information on the benefits of regular exercise and principles of RE. 
Correct exercise techniques were explained/demonstrated, and the participants became 
familiarized with RE by practicing the techniques with light weight initially and 
gradually increasing the intensity to 40% of their estimated maximum strength (4/10 on 
the Omnibus-RE Scale [OMNI-RES] ratings of perceived exertion [RPE]). (77) The 
purpose of the exercise orientation was to allow rapid motor learning while minimizing 
skeletal muscle adaptations to standardize strength measures, estimate maximum 
strength (1RM) prior to testing, and reduce the possibility of exercise-induced injury. 
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Testing 
Following the orientation and at least 72 hours before the first RET session, 
1RM, peak power, body composition, and resting metabolic rate (RMR) were measured. 
1RM’s for all the exercises included in the RET program were determined by gradually 
increasing exercise weights until the maximum resistance, at which only one repetition 
can be completed with proper form in full range of motion, was reached (77) using 
Keiser 300 series pneumatic exercise machines (Keiser, Palo Alto, CA). Following a 
three minute warm-up on a cycle ergometer (Schwinn Fitness, Inc., Denver, CO) and 
stretching, participants performed four warm-up repetitions with an exercise weight 
corresponding to 55% of an estimated 1RM based on RPE on the OMNI-RES. The 
weight was then increased to 75% of a re-estimated 1RM (based on RPE) to perform 
only one repetition. After 60 seconds of rest, the weight was increased again to 90% of a 
re-estimated 1RM to perform one repetition. Additional attempts for 1RM were made 
after 60 seconds of rest until the true 1RM value was obtained, in a manner that the total 
number of 1RM attempts was minimized (77). The same procedure was performed for 
all exercises and in the same order for all participants. 
The power (force x speed) output for each exercise was also measured during 
1RM tests. The participants were instructed to perform the concentric phase of 
repetitions at their maximal speed, and the Keiser machines calculated the power output 
for each repetition. The highest value of the power outputs recorded during 1RM tests 
was used as peak power for each exercise. 
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Body composition was assessed by dual energy X-ray absorptiometry (DEXA) 
using Lunar Prodigy (General Electric, Fairfield, CT), and RMR was measured with 
ParvoMedics TrueMax 2400 Metabolic Measurement System (Sandy, UT) in the 
morning after an overnight fast. On the first day of the RET program, fasted (12 hours, 
overnight) blood samples were collected from antecubital veins, and blood 
lipid/metabolic panels were run with standard methods at St. Joseph Regional Health 
Center’s CDC certified laboratory (Bryan, TX) to examine the effects of choline intake 
on clinical markers of liver/muscle damage and blood lipid profiles since choline 
deficiency is shown to cause liver/muscle damage and to perturb lipid metabolism (29) . 
All tests were repeated at the completion of 12 weeks of RET. 1RM and body 
composition were measured 48 and 72 hours after the last RET session, respectively, and 
the blood collection was performed on the last day of the RET. 
Resistance Exercise Training 
Participants performed a full body RET program three times per week (on non-
consecutive days) for 12 weeks using Keiser 300 series exercise machines. The RET 
program consisted of 10 minutes of warm-up on a cycle ergometer (Schwinn Fitness, 
Inc., Denver, CO), five minutes of dynamic stretching, seated chest press, lat pull down, 
leg press, calf raises, seated leg curls, knee extension, biceps curls, and triceps extension 
exercises. Participants performed three sets of 8-12 repetitions with resistance set at 70% 
of 1RM. They were instructed to perform as many repetitions as possible until they 
reached 12 repetitions or muscle failure on a given set. When a participant was able to 
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complete 12 repetitions on all three sets of an exercise, the weight was increased so that 
only eight repetitions would be possible in the next exercise session. The rest between 
each set was one minute, and the rest between each exercise was two minutes, during 
which muscle specific stretching was performed. All the exercise sessions were 
supervised by Exercise Physiology graduate students, and the participants were 
instructed to maintain their non-RET physical activities at the pre-study level, but not to 
perform any additional RET. 
Nutrition Control 
Participants were instructed to consume 50% of total calories from carbohydrate, 
30% from fat, 20% from protein, and <10% from saturated fat; to meet daily caloric 
consumption goals as determined by RMR test. They were also instructed to consume 
>1.0 g/kg/d of protein, 25-30 g/d of fiber, and <200 mg/d of cholesterol, as 
recommended by the ADA. Participants were required to maintain 24-hour diet logs at 
least four times per week (three week days and one weekend day) during the study 
period. Feedback on the diet logs were provided weekly, and adjustments were made as 
necessary to ensure adherence to the dietary guidelines of the study. 
To minimize any potential effect that the variability of protein consumption may 
have, participants consumed protein supplements (0.4 g/kg lean mass/supplement; MET-
Rx protein [MET-Rx USA Inc., Boca Raton, FL] + egg protein) every 12 hours 
throughout the study period. The supplement contained different amounts of whole egg 
powder so that Low, Med, and High groups were provided with 0.0, 2.2, or 6.8 mg of 
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choline/kg lean/d from egg yolk, respectively. Egg white powder and peanut oil was 
used to achieve equivalent amounts of protein and fat content for each group’s 
supplement, and the supplement additionally provided 0.7 mg/kg lean/d of choline as 
well as 0.9 g/kg lean/d of carbohydrate and 0.3 g/kg lean/d of fat equally for all groups.  
Thigh Muscle Quality 
From the DEXA scans of each participant, thigh muscle quality-strength (TMQ-
S) was assessed and defined as leg press 1RM (kg) / total thigh lean mass for both legs 
(kg).  Total thigh lean mass was determined through the construction of a four-sided 
polygon encompassing the entire region of each thigh and combining lean mass of both 
thighs together (Figure 5). The first line segment of the polygon consisted of one point 
(point a) inferior to the pubic bone immediately below any flesh as a reference point 
with the other point (point b) positioned as to obliquely transverse the intertrochanter 
crest of the femur bone. The next line segment transected the tibio-femoral joint (c-d), 
and two more line segments were drawn to enclose the entire thigh tissue (b-c, a-d). 
Lean mass values located inside the polygon were calculated with DEXA and defined as 
thigh lean mass. All thigh lean mass measurements were performed by two independent 
raters. Inter-rater reliability was R2>0.99, and the coefficient of variation was <1.5%. 
Deviations from these norms were reanalyzed. Means of the two raters were used for 
data analyses. 
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Figure 5. Example of DEXA Scan Image of Right Thigh  
A four-sided polygon was constructed with one point below the pubic bone (a) that was 
connected to another point (b) as to obliquely cross the intertrochanter crest of the femur 
bone. Points (c) and (d) were positioned as to be traversing the tibio-femoral joint. Points 
(b)-(c) and (a)-(d) were connected to ensure the entire thigh was encompassed. 
Data Analysis 
All statistical analyses were conducted using SAS/STAT software (version 9.4; 
SAS Institute Inc., Cary, NC). The mean intakes of all nutrients were calculated from the 
diet logs that were entered into Nutribase software (version 7; Cybersoft Inc., Phoenix, 
AZ) or direct calculations from the USDA database for choline (44). The assumption of 
normal distribution was checked using Shapiro-Wilk test, and non-normal variables were 
log transformed for parametric statistical tests. Student’s independent t-tests were used 
to compare means of two different groups (e.g., gender), and paired t-tests were 
performed to examine the difference between pre- and post-training values. Pearson 
correlations were used to examine associations between nutrient intakes and RET 
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responses (changes in lean mass and 1RM’s), and to identify potential covariates for 
further analyses. 
The differences between choline groups were analyzed by one way analysis of 
variance (ANOVA). The assumption of equal variance was checked using Levene’s test, 
and the Tukey method was used to perform pairwise comparisons. When the equal 
variance assumption was not met, Welch’s variance-weighted ANOVA test was 
performed. Analysis of covariance (ANCOVA) tests were conducted to examine the 
effect of dietary choline controlling for effects of potential confounders (cholesterol and 
other nutrients, gender, age, and/or lean mass, etc.) on RET responses. 
Multiple linear regression analyses were performed to examine the independent 
effects of choline consumption and any other factors on RET responses. Composite 
strength was defined as chest press 1RM + leg press 1RM, and percent change was 
calculated as 100 x (post training measurement - pre training measurement) / pre training 
measurement. P values of <0.05 were considered statistically significant, and data are 
presented as mean ± standard deviation (SD) unless stated otherwise. 
Results 
Demographics 
The baseline characteristics of the 37 participants who completed the 12 weeks 
of RET are presented in Table 8. There were no differences between choline groups in 
age, gender distribution, height, weight, lean mass, or adiposity. Furthermore, there were 
no significant differences between men and women in age and body fat, and BMI while 
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males were taller and had more lean and total body mass compared with females (data 
not shown). 
Table 8. Participant’s Baseline Characteristics 
Low (n=13) Med (n=11) High (n=13) P values 
Age (years)  58.9 ± 7.3  60.7 ± 4.6   60.0 ± 4.5 0.78 
Male/Female 6/7 5/6 4/9 0.69 
Height (inches)  67.2 ± 3.8  66.5 ± 3.5 65.5 ± 3.0 0.47 
Weight (kg) 83.5 ± 14.9 80.8 ± 22.9  78.5 ± 15.9 0.77 
Body fat (kg) 31.3 ± 12.2 27.7 ± 10.7 31.3 ± 7.9 0.65 
Lean mass (kg)  48.8 ± 9.7 44.6 ± 8.1  44.0 ± 11.3 0.42 
BMI (kg·m
-2
) 28.8 ± 5.8 28.1 ± 5.7 28.2 ± 4.7 0.94 
Data are presented as mean ± SD. Low: choline intake of 6.2 ± 1.2 mg/kg lean mass/d. Med: 
choline intake of 8.1 ± 1.6 mg/kg lean/d. High: choline intake of 14.2 ± 3.0 mg/kg lean/d. No 
differences were observed between choline groups. 
Nutritional Compliance 
Participants successfully followed the dietary guidelines of the study and met all 
the requirement for nutritional intake. On average, the participants consumed 27 
kcal/kg/d of calories, 3.2 g/kg/d of carbohydrate, 1.4 g/kg/d of protein, and 1.0 g/kg/d of 
fat throughout the study, and there was no difference in nutrient intake between choline 
groups except for cholesterol consumption (Table 9).   
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Table 9. Nutritional Intakes 
Low (n=13) Med (n=11) High (n=13) P values 
Total Energy (kcal/kg/d)  27.7 ± 5.8 25.6 ± 6.3 27.7 ± 6.9 0.58 
Carbohydrate (g/kg/d) 3.4 ± 0.9 3.0 ± 0.7 3.3 ± 0.8 0.39 
Protein (g/kg/d) 1.4 ± 0.2 1.4 ± 0.3 1.4 ± 0.2 0.45 
Fat (g/kg/d) 1.0 ± 0.4 0.9 ± 0.2 1.0 ± 0.4 0.36 
% of kcal from carbohydrate* 49.6 ± 4.3 47.9 ± 2.7 49.5 ± 4.9 0.58 
% of kcal from protein* 16.9 ± 3.0 18.4 ± 1.4 17.1 ± 2.3 0.25 
% of kcal from fat*  31.7 ± 4.5  31.5 ± 2.1  30.8 ± 5.8 0.86 
Folate (DFE/kg/d) 5.8 ± 1.6 6.3 ± 2.8 7.3 ± 2.1 0.21 
Vitamin B5 (mg/kg/d) 0.07 ±0.02 0.08 ± 0.05 0.09 ± 0.02 0.33 
Vitamin B6 (mg/kg/d) 0.03 ± 0.01 0.03 ± 0.01 0.03 ± 0.01 0.35 
Vitamin B12 (mcg/kg/d) 0.06 ± 0.03 0.07 ± 0.04 0.08 ± 0.03 0.16 
Betaine (mg/kg/d) 0.7 ± 0.5 0.9 ± 1.1 1.0 ± 0.9 0.61 
Cholesterol (mg/kg/d) 1.9 ± 0.4 4.0 ± 0.7 7.7 ± 1.1 <0.001 
Data are presented as mean ± SD and include values from supplement. Low: choline intake of 
6.2 ± 1.2 mg/kg lean mass/d. Med: choline intake of 8.1 ± 1.6 mg/kg lean/d. High: choline intake 
of 14.2 ± 3.0 mg/kg lean/d. * denotes values from participants’ diet only. No differences were 
observed between choline groups except for cholesterol intake. 
The mean choline consumption was 6.2 ± 1.2 mg/kg lean mass/d for Low group 
(~51% of AI), 8.1 ± 1.6 mg/kg lean/d for Med group (~68% of AI), and 14.2 ± 3.0 
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mg/kg lean/d for High group (~118% of AI). Choline intake from participants’ own diets 
was 5.9 ± 2.2 mg/kg lean/d (Low: 5.5 ± 1.2 mg/kg lean/d, Med: 5.3 ± 1.6 mg/kg lean/d, 
and High: 6.7 ± 3.0 mg/kg lean/d, p= 0.20), and the supplement provided additional 0.7, 
2.8, and 7.5 mg/kg lean/d of choline for Low, Med, and High groups, respectively. 
Choline intake (mg/kg lean/d) was significantly correlated with folate (DFE/kg lean/d, 
r=0.58, p<0.001), vitamin B5 (mg/kg lean/d, r=0.52, p=0.001), vitamin B6 (mg/kg lean/d, 
r=0.53, p<0.001), vitamin B12 (mcg/kg lean/d, r=0.59, p<0.001), and cholesterol (mg/kg 
lean/d, r=0.88, p<0.001) intakes. 
RET Responses 
RET resulted in significant increases in lean mass and strength from baseline in 
all three groups while only Low and Med groups lost significant body fat (Tables 10 
and 11). However, there was no difference between groups in changes in lean or fat 
mass. Since there was no difference between men and women in muscle responses to 
RET (men vs. women; percent change in lean mass: 3.6 ± 2.0 vs. 3.6 ± 3.6, p=0.99; 
percent change in composite strength: 41.0 ± 38.8 vs. 33.7 ± 23.5, p=0.52), data were 
pooled for further analyses. Observed correlation coefficients (r) of percent change in 
composite strength were 0.29 (p=0.097) with choline (mg/kg lean/d) and 0.31 (p=0.07) 
with betaine (mg/kg lean/d). Percent change in lean mass was correlated with vitamin B5 
intake (mg/kg lean/d, r= 0.35, p=0.04) while choline consumption was not significantly 
correlated with lean mass gains with RET (r=0.25, p=0.14). 
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Table 10. The Effect of Choline Intakes on Body Composition 
Low (n=13) Med (n=11) High (n=13) P values 
Change in lean mass (kg)  1.6 ± 1.5  1.6 ± 1.5    1.7 ± 0.9 0.95 
Percent change in lean mass  2.9 ± 3.3 3.9 ± 3.7  4.1 ± 2.3 0.58 
Change in body fat (kg) -0.8 ± 1.4   -1.2 ± 1.1  -0.6 ± 1.8 0.75 
Percent change in body fat -3.4 ± 5.8  -4.8 ± 5.0  -2.0 ± 6.7 0.55 
Data are presented as mean ± SD. Low: choline intake of 6.2 ± 1.2 mg/kg lean mass/d. Med: 
choline intake of 8.1 ± 1.6 mg/kg lean/d. High: choline intake of 14.2 ± 3.0 mg/kg lean/d. All 
changes from baseline are statistically significant except for change in body fat in High group. 
No significant differences were observed between groups. 
Since choline consumption was significantly correlated with folate, vitamin B5, 
vitamin B6, vitamin B12, and cholesterol, and RET responses were associated with 
betaine and vitamin B5, ANCOVA analyses using these and other potential confounders 
including age, lean mass, and other major dietary factors (e.g. protein intake) as 
covariates were conducted. The results showed a significant difference in percent change 
in composite strength between choline groups (Figure 6, p=0.034). Low choline group 
showed reduced composite strength gain (%) when compared with Med (p=0.035) or 
High (p=0.085) choline groups (Low: 19.4 ± 8.2%, Med: 46.8 ± 8.9%, High: 47.4 ± 
8.1%), after adjusting for covariates. The covariates appearing in the final model were 
lean mass, protein, betaine, and vitamin B12. The other potential confounders were 
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removed during the model selection/simplification processes due to their insignificant 
contribution to variability of percent gains in composite strength. 
Figure 6. The Effect of Choline Intake on Change in Composite Strength 
Data are presented as least squares mean ± standard error (SE). Low: choline intake of 
6.2 ± 1.2 mg/kg lean mass/d. Med: choline intake of 8.1 ± 1.6 mg/kg lean/d. High: 
choline intake of 14.2 ± 3.0 mg/kg lean/d. Low group gained less strength when 
compared with Med (p=0.035) or High (p=0.085) groups. Composite strength is defined 
as chest press 1RM + leg press 1RM. Covariates appearing in the model: lean mass (kg), 
protein (g/kg lean/d), betaine (mg/kg lean/d), and vitamin B12 (mcg/kg lean/d). * denotes 
a significant difference from the other groups. 
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Table 11. The Effect of Choline Intakes on Changes (%) in 1RM 
Low (n=13) Med (n=11)  High (n=13) P values 
Leg Press 25.3 ± 24.0 45.7 ± 40.2 50.3 ± 46.4 0.22 
Chest Press 25.4 ± 13.4 23.0 ± 15.1  31.0 ± 24.0 0.55 
Lat Pull Down 17.2 ± 13.3 23.1 ± 26.7 30.6 ± 23.7 0.30 
Knee Extension 21.7 ± 23.0 14.8 ±30.3 37.5 ± 44.9 0.27 
Leg Curls 20.9 ± 19.9 35.6 ± 25.0 36.0 ± 26.6 0.21 
Triceps Extension 26.8 ± 17.6 31.0 ± 21.2 36.8 ± 27.5 0.53 
Biceps Curls 41.4 ± 52.8  38.2 ± 26.0 36.8 ± 39.8 0.96 
Data are presented as mean ± SD. Low: choline intake of 6.2 ± 1.2 mg/kg lean mass/d. Med: 
choline intake of 8.1 ± 1.6 mg/kg lean/d. High: choline intake of 14.2 ± 3.0 mg/kg lean/d. All 
changes from baseline are statistically significant, but no significant differences were observed 
between groups. 
Since RET responses in Med and High groups were similar (Figure 6, Table 11), 
additional analyses were conducted after the Med and High groups were pooled. 
Independent t-test results showed significant differences between Low and Med-High 
groups in changes (%) in leg press 1RM (Low: 25.3 ± 24.0 vs. Med-High: 48.2 ± 42.8, 
p<0.05) and composite strength (Low: 129.9 ± 84.2 vs. Med-High: 182.1 ± 147.3, 
p=0.05). ANCOVA analysis using lean mass (kg), protein (g/kg lean/d), betaine (mg/kg 
lean/d), and vitamin B12 (mcg/kg lean/d) as covariates also showed that Low group had 
significantly diminished thigh muscle quality-strength (TMQ-S) improvements 
compared with Med-High group while differences in leg press and composite peak 
power were not statistically significant (Table 12). 
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Table 12. The Effect of Choline Intakes on Changes (%) in Peak Power and Thigh Muscle 
Quality 
Low (n=13) Med-High (n=24) P values 
Leg Press Peak Power (W) 19.0 ± 13.5  30.0 ± 22.4 0.072 
Composite Peak Power (W) 17.4 ± 12.5 25.5 ± 17.3 0.110 
TMQ-S† 12.3 ± 9.6  46.4 ± 7.0 0.010 
Data are presented as mean ± SD. Composite Peak Power: Leg press peak power + Chest press 
peak power. TMQ-S = leg press 1RM (kg) / total thigh lean mass for both legs (kg). All changes 
from baseline were statistically significant. † denotes ANCOVA analysis results presented as 
least squares mean ± standard error (SE). Covariates appearing in the model: lean mass (kg), 
protein (g/kg lean/d), betaine (mg/kg lean/d), and vitamin B12 (mcg/kg lean/d). 
Multiple linear regression analyses were also conducted to evaluate independent 
association of dietary choline and other nutrients as well as aforementioned potential 
confounders. All variables were initially entered into the regression equation, and the 
variables were sequentially removed at each step with backward elimination method. 
The final model showed that Low choline intake independently predicted percent change 
in composite strength, with betaine intake, male gender, and lean mass remaining in the 
model (adjusted R2=0.215, p=0.02, Table 13). Even though cholesterol was previously 
shown to be associated with strength and lean mass gains (69), it did not predict 
variability of strength gains in the present study. 
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Table 13. Multiple Regression Analysis of the Independent Effect of Low Choline Intake, Lean 
Mass, and Betaine Intake on Change (%) in Composite Strength Following 12 Weeks of RET 
Unstandardized Coefficients 
Predictors β SE  P values 
(Intercept) 0.86 1.04 0.42 
Low Choline Intake -0.62 0.27  0.03 
Male Gender -0.89 0.50 0.09 
Lean Mass (kg) 0.00006 0.00003 0.03 
Betaine Intake (mg/kg/d) 0.23 0.11 0.04 
SE: standard error. Low Choline Intake: choline consumption of 6.2 ± 1.2 mg/kg lean mass/d. 
Blood Lipids and Liver Damage Markers 
Since choline deficiency is reported to cause liver/muscle damage and altered 
lipoprotein/blood lipid metabolism, blood markers for liver damage (alanine 
aminotransferase [ALT] and aspartate aminotransferase [AST]) and muscle damage 
(creatine kinase [CK]) and blood lipid profiles (triacylglycerol [TAG], total cholesterol, 
high density lipoprotein cholesterol [HDL-C], and low density lipoprotein cholesterol 
[LDL-C]) were also measured. The results showed no effect of choline intake on any of 
these clinical blood markers (Table 14). 
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Table 14. The Effect of Choline Intakes on Pre and Post RET Values of Select Blood Lipids 
and Enzymes 
Low (n=10)* Med (n=10)* High (n=10)* P values† 
ALT (U/L) 
Pre 42.3 ± 8.6   32.6 ± 9.6 39.4 ± 24.9 0.36 
Post 36.5 ± 8.7 35.6 ± 14.9 37.2 ± 12.1 0.96 
AST (U/L) 
Pre 38.4 ± 11.1 28.7 ± 5.4 35.0 ± 16.5 0.17 
Post 33.4 ± 7.8 32.9 ± 9.2 31.2 ± 9.2 0.83 
Total cholesterol 
(mg/dL) 
Pre 184.4 ± 25.7 193.9 ± 20.3 181.2 ± 31.3 0.53 
0.08 Post 176.8 ± 15.1 206.3 ± 29.8 191.6 ± 36.4 
HDL-C (mg/dL) 
Pre 55.8 ± 10.7 55.2 ± 10.4 52.8 ± 12.4 0.81 
Post 53.2 ± 9.2 54.8 ± 9.5 53.9 ± 12.8 0.94 
LDL-C (mg/dL) 
Pre 107.8 ± 20.6 115.3 ± 20.1 104.0 ± 30.6 0.57 
Post 104.1 ± 16.2 127.0 ± 31.1 111.6 ± 33.4 0.18 
TAG (mg/dL) 
Pre 103.8 ± 34.6 117.1 ± 48.9 122.3 ± 78.6 0.73 
Post 97.1 ± 37.5 122.2 ± 62.0 131.4 ± 80.0 0.42 
CK (U/L)* 
Pre 119.0 ± 50.4 98.7 ± 47.9 128.1 ± 78.9 0.70 
Post 77.3 ± 25.4 85.8 ± 41.4 99.3 ± 29.3 0.54 
Data are presented as mean ± SD. *: Sample sizes are reduced due to blood sample availability 
(n’s for CK: Low=4, Med=6, High=8; CK was measured in blood samples taken 48 hours after 
the 1st and last exercise sessions of RET). Low: choline intake of 6.2 ± 1.2 mg/kg lean mass/d. 
Med: choline intake of 8.1 ± 1.6 mg/kg lean/d. High: choline intake of 14.2 ± 3.0 mg/kg lean/d. 
ALT: alanine aminotransferase, AST: aspartate aminotransferase, HDL-C: high density 
lipoprotein cholesterol, LDL-C: low density lipoprotein cholesterol, TAG: triacylglycerol. CK: 
creatine kinase. † denotes p values for between group comparisons. There was no difference 
between or within groups in any of the blood marker concentrations. 
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Discussion 
The purpose of the present study was to examine the effects of choline 
supplementation in the form of egg yolk (approximately zero, one, or three additional 
egg yolks per day) on strength gains and lean mass changes with 12 weeks of RET in 
older men and women. The major finding of the present study was that low choline 
intake (~50% of AI) negatively affects strength gains with 12 weeks of RET in 50 to 69 
year old individuals, which is consistent with our other findings (76). Our data also 
suggest that choline intake greater than AI may not provide additional positive effect on 
RET responses. 
There have been several studies that examined the effect of choline 
supplementation on exercise performance, and the results showed that choline 
consumption above AI did not positively affect exercise performance. However, these 
studies utilized acute bouts of aerobic/endurance exercise protocols, thus direct 
comparison to our study is somewhat difficult (14-17). One study that examined the 
effect of chronic choline supplementation on performance outcomes utilizing an 
anaerobic exercise protocol (18) had college students perform a four minute reaction 
test, a 30 minute Wingate Anaerobic Power test, and maximum number of push-ups and 
sit-ups for one minute after taking ~50mg of choline or placebo. The subjects repeated 
the same tests after four weeks of the supplement/placebo consumption, and the results 
showed no acute or chronic effect of choline supplementation on exercise performance. 
However, since the exercise loads used for testing were very light, there was no 
nutritional control, and the amount of choline in the supplement was small and mixed 
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with other ingredients such as caffeine, it is difficult to interpret their results as related to 
RET responses. 
Choline may affect muscle responses to RET through one or many potential 
mechanisms. Since choline is a precursor to a neurotransmitter, ACh, which relays a 
signal from motor neurons to skeletal muscle to contract and generate force, and of 
which synthesis is reported to be affected by availability of choline (4, 5), insufficient 
choline consumption may limit the availability of ACh at neuromuscular junction (NMJ) 
and in turn, muscle contraction and force generation. ACh is synthesized in cholinergic 
nerves by choline acetyltransferase (ChAT) using acetyl-CoA and choline as substrates. 
After it is released into the synaptic cleft and binds to ACh receptors on the muscle 
membrane, it is broken down to acetate and choline by ACh esterase. Choline is then 
taken up by choline transporter proteins on nerve cells and recycled to re-synthesize 
ACh by ChAT. 
Crockett et al. (78) reported that ChAT activity is inversely related to the size of 
the muscle fiber and positively related to muscle fiber’s resistance to fatigue. Since fast 
twitch (FT) muscle fibers are in general larger in size and less resistant to fatigue, ChAT 
activity may be lower in FT fibers, and FT fibers may have less ability to recycle choline 
and re-synthesize ACh, making them more sensitive to and reliant on choline supplied 
by the circulation (eventually from diet), compared with slow twitch (ST) fibers. Since 
FT fibers are mostly recruited and utilized with RE, if choline affects RET responses via 
ACh, this may explain, at least in part, why choline intake may influence muscle 
responses to endurance exercise and RE differently. Moreover, Herscovich and Gershon 
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(79) reported that aging decreases activities of ChAT, suggesting that the importance of 
sufficient choline intake may be amplified in the older population. 
Choline can also influence methylation reactions. A portion of choline is 
irreversibly converted to betaine, which is used to convert homocysteine to methionine, 
which is then used to generate S-adenosyl methionine (SAM), a universal methyl group 
donor. Therefore, choline and its metabolite betaine may affect methylation, which plays 
crucial roles in lipid synthesis, epigenetic control of gene expression/protein synthesis, 
and regulation of many other metabolic pathways (10, 28). 
Since betaine, via SAM, may contribute to synthesis of creatine, and is an 
important osmolyte maintaining fluid balance, studies have been conducted to examine 
the effect of betaine ingestion on exercise performance and body composition. The 
results generally showed positive effects of betaine on performance and body 
composition, with some inconsistencies (80). For example, body composition was 
favorably affected, and training volume was increased with six weeks of betaine 
supplementation in Cholewa et al.’s study (81) whereas 10 days of betaine 
supplementation did not affect muscle creatine content, or 1RM/power of bench 
press/squat in another study (82). Also, Hoffman et al. (83) reported 15 days of betaine 
supplementation did not increase peak force on isokinetic chest press in college-aged 
men while Lee et al. (84) reported 14 days of betaine supplementation resulted in 
increased vertical jump power and isometric squat force. In the present study, together 
with choline, betaine was independently associated with change (%) in composite 
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strength suggesting multiple mechanisms are at work. Future studies are warranted to 
investigate the independent roles that choline and betaine each plays on RET responses. 
Choline is also a precursor to PC, the predominant form of phospholipid in all 
cell membranes. PC is also a precursor to many other components in membranes 
including sphingomyelin and phosphatidylserine. Therefore, choline contributes to the 
stability and integrity of cell membranes, and choline deficiency results in weakened cell 
membranes and leakage of intracellular enzymes to the circulation. da Costa et al. (6) 
reported that blood levels of creatine kinase (CK), a muscle cell damage marker, 
increased up to 66 fold with severely low (<10% of AI) choline intake. Insufficient 
choline consumption and the resultant decrease in cytidine diphosphocholine (CDP-
choline) pathway (which makes PC from dietary choline) can also lead to perturbation of 
PC homeostasis and induce cell death (85). Therefore, choline deficient diets may result 
in weak and compromised cell membrane/structure, which may negatively affect skeletal 
muscle’s ability to withstand mechanical stresses imposed by exercise, especially during 
RET. 
However, we did not observe negative effects of low choline consumption on 
plasma CK concentrations. This may be explained by the difference in the amount of 
choline intakes between da Costa et al.’s (6) study (<10% of AI) and the present study 
(Low group: ~50% of AI). It appears that only severely low choline intake may induce 
muscle cell membrane damage and leakage of CK into the circulation. The similar 
results were observed with liver damage markers. In the present study, there was no 
effect of low choline intake on blood concentrations of ALT and AST, suggesting that 
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only severely deficient choline consumption may result in release of those enzymes. 
However, hepatic steatosis was observed in a previous study (38) without leakage of 
ALT or AST in many subjects in response to a choline deficient diet, suggesting that 
liver dysfunction can occur even without increases in intracellular enzyme 
concentrations in the blood. It remains to be determined whether moderately low choline 
intake (as in the present study) can subtly compromise and weaken membrane integrity 
negatively affecting muscle functions while still not allowing leakage of intracellular 
enzymes into the circulation. 
We have also examined the effect of choline intake on blood lipid profiles, since 
total blood cholesterol and LDL-C were previously reported to be positively associated 
with lean mass gains (69), and dietary choline influences synthesis of lipoproteins that 
transport cholesterol and fat in the circulation (24). However, there was no effect of 
choline consumption on any of the blood lipids and lipoproteins, indicating that 
moderately low choline intake does not negatively affect blood lipid profiles. 
In addition, while dietary cholesterol was previously reported to be associated 
with lean mass and strength gains with RET in older adults (69), it did not contribute 
much to the variability of strength gains in the present study. The reason for this 
discrepancy is unclear, but it can be speculated that the results of the previous study may 
have been confounded by inability to separate choline’s effect from that of cholesterol 
because information on choline content of foods was not widely available when the 
previous study was conducted. Since many choline rich foods are also rich in 
cholesterol, future studies may need separate administration of choline and cholesterol to 
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examine the independent roles that choline and cholesterol each plays on skeletal muscle 
responses to RET. 
Our study has some limitations including the inability to determine mechanisms 
through which choline may affect RET responses. Since we have consistently observed 
effects of dietary choline (especially the negative effects of low choline intake [~50% of 
AI]) on muscle responses to RET, future studies should be focused on elucidating the 
mechanism(s) of choline’s effect. Also, the well-known tendency to under-report food 
intake associated with diet logs may have obscured the accuracy of our data (86). 
However, we believe that, compared with the three-to-four-day food records commonly 
used in nutrition studies or the seven-day weighed food records which are considered as 
the best method currently, >48 day food records (at least four days of diet records/week 
for the entire 12 weeks) we required from our participants have minimized the issues 
related to inaccurate reporting of food intake. We also expect that error associated with 
this method would be consistent across choline groups. 
Summary 
Our data suggest that low choline intake (~50% of AI) for 12 weeks may impair 
strength gains with RET in 50-69 year old generally healthy individuals, that is 
consistent now in two studies, whereas higher choline intake (greater than AI) may not 
have additional benefits on strength gains. However, choline intake did not affect change 
in lean mass in the present study, which is inconsistent with our other findings. It 
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appears that having inadequate dietary choline may have a negative effect on strength 
gains but subtle or no effect on lean mass changes. 
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CHAPTER V 
THE EFFECTS OF 3 WEEKS OF RESISTANCE EXERCISE AND CHOLINE 
SUPPLEMENTATION ON EMG AMPLITUDE AND STRENGTH RESPONSES IN 
50-65 YEAR OLDS: A RANDOMIZED DOUBLE-BLIND PLACEBO-
CONTROLLED TRIAL 
Introduction 
Choline is an essential nutrient playing important roles in many physiological 
processes including membrane formation/signaling, lipid transport, methylation, 
reduction of homocysteine, and brain/memory development (29). Choline is also a 
precursor to acetylcholine (ACh), the main neurotransmitter of α-motor neurons, which 
mediates muscle contraction and force generation. Therefore, dietary choline may affect 
exercise performance through availability of ACh at the neuromuscular junction (NMJ) 
and/or other mechanisms listed above. Even though a limited number of studies 
examined the relationship between choline and exercise performance, the results were 
equivocal, perhaps because previous studies lacked control of dietary choline intake and 
only examined the effects associated with endurance exercise (14-17). Considering the 
difference between endurance and resistance exercises (RE) in muscle fiber recruitment 
and nerve firing patterns (i.e., low vs. high frequency neural activation rate, 
respectively), it is reasonable to hypothesize that dietary choline may influence muscle 
responses to the two different exercise modes differently. 
ACh transmits action potentials from motor neurons to skeletal muscle through 
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NMJ (87). When action potentials travel to skeletal muscle via ACh, electrical waves are 
formed along the surface of muscle fibers (30), and these electrical activities can be 
measured by electrodes placed on the skin surface enclosing the activated muscle fibers 
(88). The surface electromyography is a non-invasive method to detect electrical 
activities of skeletal muscle, and surface electromyogram (EMG) represents global 
electrical activities of motor unit (MU). The amplitude of surface EMG reflects the net 
MU activity which consists of recruitment and rate coding of active MUs (88), and EMG 
can be used as an indirect tool to examine the activities of motor neurons, which are 
mediated by ACh. 
Any change in EMG amplitude can be interpreted as changes in motor 
neuron/NMJ functions or membrane conductivity. However, Warren et al. (71) reported 
that membrane conductivity was not impaired even after muscle damaging, high volume 
eccentric contractions. They also reported that EMG amplitude was reduced by 59% 
when 3 mg/kg of succinylcholine (a competitive inhibitor of ACh) and 0.4 mg/kg of 
tubocurarine (antagonist of ACh receptor) were administered to partially block ACh at 
the NMJ in mice (71). In addition, Suzuki et al. (72) observed a marked decrease in 
EMG amplitude after administration of vesamicol hydrochloride which inhibits ACh 
release from the motor nerve terminals in cats. Therefore, EMG amplitude can represent 
ACh status at the NMJ, and if dietary choline affects muscle responses through ACh 
availability, it can be reflected on EMG amplitudes. 
We have previously reported that 12 weeks of low choline intake (~50% of 
Adequate Intake [AI]) resulted in diminished strength and/or lean mass gains in older 
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men and women in response to resistance exercise training (RET) in two separate study 
populations (76, 89). However, it is unclear whether low choline consumption for a 
shorter period of time (<one month) still has negative effects on muscle responses to RE. 
Also unclear is whether ACh availability is the main mechanism through which dietary 
choline affects skeletal muscle function and exercise performance. 
The purpose of the present study was to determine whether varying levels of 
choline consumption for less than one month have any effects on changes in 
neuromuscular activation and strength in response to RE in older adults. We also 
measured clinical markers of liver/muscle damage and blood lipids since choline 
deficiency was reported to cause liver/muscle damage and perturbation of lipid 
metabolism (29). We hypothesized that 3 weeks of moderately low choline consumption 
would result in reduced neuromuscular activation (EMG amplitudes), isometric force 
production, and strength gains compared with higher choline intake, without affecting 
liver/muscle damage markers and/or blood lipid profiles. 
Methods 
Participants 
Thirty-one, generally healthy, previously untrained, community dwelling, 50-65 
year old males and females (post-menopausal for more than a year), recruited through 
emails, flyers, and newspaper advertisement, underwent 3 weeks of diet/RE intervention. 
Individuals with following conditions were excluded: resting blood pressure of >160/100 
mmHg, cardiac arrhythmias, hernia, aortic aneurysm, kidney disease, lung disease, 
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smoking habit, diabetes, participation in RET program of one hour or more per week in 
the previous 12 months. All participants provided written informed consent prior to 
participation, and the study protocol was approved by Texas A&M University 
Institutional Review Board. 
Pre-Study Orientation 
Prior to the start of the study, participants had one week of an orientation period 
during which they attended two sessions of nutrition education and exercise 
familiarization. Participants learned about optimal nutrient intake, serving size/portion 
control, study specific diet requirements, general information about RE, and proper 
forms/techniques of RE. They also became familiarized with the exercises to be 
performed during the study, by practicing the techniques with light resistance 
(approximately 40% of estimated maximum strength [1RM] based on the Omnibus-RE 
Scale [OMNI-RES] ratings of perceived exertion [RPE]) (77). The purpose of the 
exercise orientation was to reduce the possibility of injury and standardize strength 
measures by inducing rapid motor learning. 
Nutritional Control 
Following the orientation, participants started recording their daily food intakes 
using nutrition software (Nutribase; version 10; Client Intake Module; Cybersoft Inc., 
Phoenix, AZ). Body composition was measured with dual energy X-ray absorptiometry 
(DEXA; Lunar Prodigy, General Electric, Fairfield, CT), and the participants were 
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randomly assigned to one of three choline groups (Low: 0.7 mg/kg/d, Med: 3.2 mg/kg/d, 
and High: 5.7 mg/kg/d of supplemental choline, respectively) in a double-blind manner 
and underwent three weeks of diet intervention. During the intervention, the participants’ 
choline consumption from their own diet was limited to approximately 3 mg/kg/day 
(~43% of AI) by limiting choline rich foods such as egg yolk, liver, organ meat, etc. 
(90), and each group’s choline requirement was met with daily supplementation of 
choline bitartrate powder (Prescribed For Life, Fredericksburg, TX), mixed in a protein 
drink (Boost High Protein; Nestle S.A., Vevey, Switzerland) which additionally 
provided 0.2 g/kg/d of protein, 0.44 g/kg/d of carbohydrate, 0.08 g/kg/d of fat, and 0.7 
g/kg/d of choline equally for all participants. Foods high in betaine such as spinach, beet, 
and wheat bran/germs were also limited in order to minimize potential effects of betaine 
intake on choline availability (24, 90). 
Each participant’s daily caloric goal was calculated with Mifflin-St Jeor equation 
(91), and the participants were instructed to consume 50% of total energy from 
carbohydrate, 30% from fat, 20% from protein, and <10% from saturated fat; and to 
consume >1.0 g/kg/d of protein, as recommended by the Academy of Nutrition and 
Dietetics. Participants were required to maintain and submit daily diet logs during the 
entire period of the study, and feedback was provided weekly to ensure participants’ 
compliance to the study specific diet guidelines. 
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Resistance Exercise 
The participants performed four bouts (on days 10, 12, 17, and 19; Figure 7) of 
high intensity leg press and leg extension exercises with emphasis on eccentric 
contractions on Keiser 300 pneumatic exercise equipment (Keiser, Palo Alto, CA). The 
exercises were performed after a 10-minute warm-up on a cycle ergometer (Schwinn 
Fitness, Inc., Denver, CO), and the participants performed three sets of each exercise 
with 8-12 repetitions per set, with resistance set at 75% of 1RM. When a participant 
achieved 12 repetitions on all three sets of an exercise, the resistance was increased so 
that only eight repetitions would be completed in the next exercise session. The rest 
between each set was one minute, and the rest between the exercises was two minutes. 
All the exercise sessions were supervised by Exercise Physiology graduate students, and 
the participants were instructed not to perform any RE outside of the study program but 
to maintain their usual non-resistance type activities at the current level. 
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Figure 7. Study Timeline 
EMG: surface electromyogram on rectus femoris muscles. 1RM: maximum strength tests of leg 
press and leg extension. RE: resistance exercises (leg press and leg extension; 8-12 reps, 3 sets 
for each exercise, 75% of 1RM). 
Testing 
1RM tests on leg press and leg extension exercises were conducted on the first 
(d1; 9 days prior to the first RE session) and the last (d22; 72 hours after the last RE 
session) days of the study using a standard method (77) by progressively increasing 
exercise weight until the maximum resistance was reached at which only one repetition 
was successfully completed with proper form throughout the entire range of motion. The 
details of 1RM procedure were described elsewhere (89), and 1RM test was performed 
in a manner that the total number of 1RM attempts was minimized. Blood samples were 
collected from antecubital veins using 10 ml Vacutainer tubes four times throughout the 
study (on days 1, 8, 15, and 22), and complete metabolic panels were run at St. Joseph 
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Regional Health Center’s CDC certified laboratory (Bryan, TX) to measure muscle/liver 
damage markers and lipid profiles in blood. 
Four times over the three weeks of the study (on days 1, 8, 15, and 22; Figure 7), 
maximal isometric force (MIF) outputs were measured using Kin-Com 125 AP 
dynamometer (Isokinetic International; Chattanooga, TN) at four different angles 
(starting at 90°, then 75°, 60°, and 45°; 0° is full extension) of knee extension with 
participants’ dominant legs. Participants were instructed to maximally contract their 
quadriceps muscles exerting 100% of force and maintain the maximal contraction for 
five seconds at each angle. The rest between angles was 10 seconds, and all participants 
conducted the tests in the same order of the knee angles. Peak force and average force 
was assessed during the MIF knee extension tests, and feedback to participants was 
displayed on the monitor screen as a time-force curve (on X and Y axis respectively) 
during the tests. 
To monitor neural/muscle activation status, a surface EMG was obtained with 
3M Red Dot self-adhering sticky gel Ag/AgCl monitoring electrodes (3M; St. Paul, MN) 
attached to participants’ rectus femoris muscles during the MIF tests. Prior to placement 
of the electrodes, participants’ skin was shaved as needed, cleaned with alcohol wipes 
containing 70% isopropyl alcohol to remove oily residue, and gently abraded with 3M 
Red Dot Trace Prep abrasive tape (3M; St. Paul, MN) to reduce skin impedance and 
enhance trace quality. Two electrodes were placed at the mid-point on the line 
connecting the anterior superior iliac spine and the superior center of the patella, in the 
longitudinal direction of the rectus femoris muscle. The electrode size was 8 mm, inter-
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electrode distance was 5 cm, and reference (earth) electrode was placed around the 
ankle. The EMG signal was amplified, band pass filtered (10-450 Hz), sampled at 1,000 
Hz, and processed using FE132 bio-amp, PowerLab data acquisition system, and 
LabChart Pro software (version 7; ADInstruments; Colorado Springs, CO). All EMG 
data are expressed as root mean square (RMS) normalized to the baseline values 
obtained during MIF test on day 1 for comparison within and between choline groups. 
EMG procedures were performed following the guidelines by International Society of 
Electrophysiology and Kinesiology (ISEK) (92) and Surface EMG for the Non-Invasive 
Assessment of Muscles (SENIAM) (93). 
Data Analysis 
All statistical analyses were conducted using IBM SPSS Statistics software 
(version 23; IBM Corporation, Armonk, NY). The mean intake values of all 
macro/micro nutrients were calculated from the 21 daily diet logs that were entered into 
Nutribase computer software (version 10; Cybersoft Inc., Phoenix, AZ), or using the 
USDA database for choline (44). Student’s independent t-tests were used to compare 
means of two different groups (e.g., gender), and paired t-tests were performed to 
examine the difference between pre- and post-study values. The Pearson correlation was 
used to examine associations between nutrient intakes and muscle responses to RE. 
The differences between and/or within choline groups were analyzed by one-way 
analysis of variance (ANOVA) and two-way repeated measure ANOVA (group x time). 
The assumptions of equal variance and sphericity were checked using Levene’s and 
88 
Mauchly’s tests respectively, and the Bonferroni method was used to perform pairwise 
comparisons. When the equal variance assumption was not met, Welch’s variance-
weighted ANOVA test was performed. Analysis of covariance (ANCOVA) tests were 
conducted to examine the effect of dietary choline controlling for the effects of potential 
confounders (other nutrients, gender, age, and/or lean mass, etc.) on muscle responses. 
Percent change was calculated as 100 x (post-study measurement - pre-study 
measurement) / pre-study measurement. P values of <0.05 were considered statistically 
significant, and data are presented as mean ± standard deviation (SD) unless stated 
otherwise. 
Results 
Participants 
The baseline characteristics of the 31 participants who completed the study are 
presented in Table 15. There were no significant differences in age, gender distribution, 
height, body weight, lean mass, or body fat percentage between choline groups. Also, 
there were no significant differences between genders in age and adiposity while men 
were taller and had more lean and total body mass compared with women (data not 
shown). 
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Table 15. Participant’s Baseline Characteristics 
Low (n=10) Med (n=11) High (n=10) P values 
Age (years)  59.2 ± 4.1  59.0 ± 5.0   59.2 ± 4.3 0.993 
Male/Female 4/6 2/9 4/6 0.459 
Height (inches)  68.2 ± 3.3  66.4 ± 3.6 67.5 ± 5.1 0.581 
Weight (kg) 80.5 ± 35.9 80.8 ± 16.2  81.6 ± 24.7 0.995 
Lean mass (kg)  50.0 ± 17.8 46.0 ± 9.3  51.4 ± 16.0 0.610 
Body fat (%) 33.0 ± 10.2 40.0 ± 9.0 34.0 ± 9.1 0.195 
Data are presented as mean ± SD. Low: choline intake of 3.6 ± 0.6 mg/kg/d. Med: choline intake 
of 6.0 ± 0.6 mg/kg/d. High: choline intake of 8.8 ± 0.8 mg/kg/d. No differences were observed 
between choline groups. 
Nutritional Intakes 
Participants successfully met all the study specific requirements for nutritional 
intake. During the three weeks of the study, they consumed 25 kcal/kg/d of calories, 3.2 
g/kg/d of carbohydrate, 1.2 g/kg/d of protein, and 0.9 g/kg/d of fat on average, and there 
was no difference in nutrient intake between choline groups except for cholesterol 
(Table 16). Participants’ consumption of the macro/micro nutrients met or exceeded 
nutritional recommendations (Dietary Reference Intakes [DRI]), except for folate 
(consumed 82% of DRI) and betaine (DRI has not been set) (94). 
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Table 16. Nutritional Intakes 
Low (n=10) Med (n=11) High (n=10) P values 
Total Energy (kcal/kg/d) 27.1 ± 7.6 24.0 ± 3.7 24.0 ± 5.4 0.372 
Carbohydrate (g/kg/d) 3.4 ± 0.9 3.0 ± 0.5 3.1 ± 0.9 0.547 
Protein (g/kg/d) 1.2 ± 0.3 1.2 ± 0.2 1.1 ± 0.2 0.754 
Fat (g/kg/d) 0.9 ± 0.3 0.9 ± 0.2 0.8 ± 0.2 0.588 
Folate (DFE/kg/d) 4.2 ± 2.5 4.0 ± 1.7 3.9 ± 1.9 0.925 
Vitamin B5 (mg/kg/d) 0.07 ± 0.04 0.07 ± 0.02 0.07 ± 0.02 0.932 
Vitamin B6 (mg/kg/d) 0.03 ± 0.01 0.03 ± 0.01 0.02 ± 0.01 0.278 
Vitamin B12 (mcg/kg/d) 0.09 ± 0.07 0.06 ± 0.02 0.07 ± 0.03 0.279 
Betaine (mg/kg/d) 0.7 ± 0.2 0.7 ± 0.1 0.9 ± 0.8 0.601 
Cholesterol (mg/kg/d) 2.3 ± 0.6 2.1 ± 0.4 1.7 ± 0.3* 0.026 
Data are presented as mean ± SD and include values from diet and supplement. Low: choline 
intake of 3.6 ± 0.6 mg/kg/d. Med: choline intake of 6.0 ± 0.6 mg/kg/d. High: choline intake of 
8.8 ± 0.8 mg/kg/d. No differences were observed between choline groups except for cholesterol 
intake. * denotes a statistically significant difference from Low group (p<0.05). 
The average choline consumption was 3.6 ± 0.6 mg/kg/d for Low group (~51% 
of AI), 6.0 ± 0.6 mg/kg/d for Med group (~86% of AI), and 8.8 ± 0.8 mg/kg/d for High 
group (~126% of AI). The mean choline intake from the participants’ own diets was 2.9 
± 0.6 mg/kg/d (Low: 2.9 ± 0.6 mg/kg/d, Med: 2.8 ± 0.6 mg/kg lean/d, and High: 3.1 ± 
0.8 mg/kg lean/d, p= 0.20), and the supplement provided additional 0.7, 3.2, and 5.7 
mg/kg/d of choline for the Low, Med, and High groups, respectively. 
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Maximum Strength 
Four sessions of leg press/leg extension resulted in significant increases in 
strength from baseline in all three groups except for leg extension in the High group 
(Table 17). However, there was no difference between choline groups in changes in 
1RMs. Since there was no difference between men and women in strength responses 
(men vs. women; percent change in leg press 1RM: 13.0 ± 14.6 vs. 16.4 ± 8.9, p=0.514; 
percent change in leg extension 1RM: 9.5 ± 17.3 vs. 14.0 ± 14.6, p=0.385) and nutrient 
intakes (data not shown), they were pooled for further analyses. 
No nutrient was correlated with changes (%) in leg press or leg extension 1RM 
while percent change in leg extension 1RM was correlated with percent changes in 
isometric knee extension peak force at 90º (r=0.415, p=0.032) and 60º (r=0.524, 
p=0.004). ANCOVA tests using various potential confounders (e.g., age, gender, lean 
mass, and/or other nutrients including cholesterol and folate) as covariates also showed 
no difference between choline groups in changes in leg press or leg extension 1RMs 
(data not shown). 
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Table 17. The Effect of Choline Intakes on Changes in 1RM 
Low (n=10) Med (n=10)§ High (n=10) P values 
Leg Press (kg) 62.6 ± 81.0 87.8 ± 54.0 91.0 ± 74.6 0.622 
Leg Press (%Δ)  12.4 ± 12.0  17.5 ± 10.7    15.8 ± 10.7 0.588 
Leg Extension (kg) 15.6 ± 13.9   9.5 ± 5.4 4.2 ± 13.5§† 0.117 
Leg Extension (%Δ) 17.9 ± 13.0 15.3 ± 18.8 5.9 ± 12.2§† 0.209 
Data are presented as mean ± SD. Low: choline intake of 3.6 ± 0.6 mg/kg/d. Med: choline intake 
of 6.0 ± 0.6 mg/kg/d. High: choline intake of 8.8 ± 0.8 mg/kg/d. §: Sample sizes are reduced due 
to data availability. N’s for Leg Extension: High=9. All changes from baseline are statistically 
significant except for † (not significant). No significant differences were observed between 
groups. 
Isometric Forces and EMG Amplitudes 
There was no significant effect of time, choline group, or time x group 
interaction on average or peak force outputs at four different knee angles except for 45º 
where there were significant time effects between days on both of the force outputs 
(p<0.01) (Figures 8 and 9). Similarly, no differences were observed in EMG amplitudes 
within or between choline groups except for 75º where there was a significant linear 
effect of time between days (p=0.018) (Figure 10). There was no effect of group x time 
interaction on EMG amplitudes. 
Average and peak isometric forces were highly correlated with EMG amplitudes 
at each respective knee angle and time point (r=0.40 to 0.90, p=0.027 to <0.001). 
ANCOVA analyses also did not show any effects of choline on isometric forces or EMG 
amplitudes after controlling for various potential confounders such as age, gender, lean 
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mass, and/or other nutrients that may influence choline and ACh metabolism such as 
vitamin B5 (pantothenic acid, the backbone of acetyl-CoA which is used for synthesis of 
ACh from choline), folate, and betaine (data not shown). 
Figure 8. The Effect of Choline Intake on Changes (%) in Average Isometric Forces 
Data are presented as mean ± standard error (SE). Low: choline intake of 3.6 ± 0.6 mg/kg/d. 
Med: choline intake of 6.0 ± 0.6 mg/kg/d. High: choline intake of 8.8 ± 0.8 mg/kg/d. No 
significant differences were observed within or between groups except for 45º where there was 
a significant time effect between days (p=0.004). 
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Figure 9. The Effect of Choline Intake on Changes (%) in Peak Isometric Forces 
Data are presented as mean ± standard error (SE). Low: choline intake of 3.6 ± 0.6 mg/kg/d. 
Med: choline intake of 6.0 ± 0.6 mg/kg/d. High: choline intake of 8.8 ± 0.8 mg/kg/d. No 
significant differences were observed within or between groups except for 45º where there was 
a significant time effect between days (p=0.001). 
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Figure 10. The Effect of Choline Intake on Changes in EMG Amplitudes 
Data are presented as mean ± standard error (SE) of RMS values normalized for baseline. Low: 
choline intake of 3.6 ± 0.6 mg/kg/d. Med: choline intake of 6.0 ± 0.6 mg/kg/d. High: choline 
intake of 8.8 ± 0.8 mg/kg/d. No significant differences were observed within or between groups 
except for 75º where there was a significant effect of time between days (p=0.018). 
Blood Lipids and Liver Damage Markers 
Since choline deficiency (<10% of AI) results in liver/muscle damage and altered 
lipoprotein/blood lipid profiles, blood concentrations of clinical markers of liver damage 
(alanine aminotransferase [ALT] and aspartate aminotransferase [AST]) and muscle 
damage (creatine kinase [CK]) and blood lipids (triacylglycerol [TAG], total cholesterol, 
high density lipoprotein cholesterol [HDL-C], and low density lipoprotein cholesterol 
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[LDL-C]) were measured. The results showed no effect of choline intake on any of these 
clinical blood markers (Table 18). 
Table 18. The Effect of Choline Intakes on Pre and Post Study Values of Select Blood Lipids 
and Enzymes 
Low (n=10) Med (n=11) High (n=10) P values† 
ALT (U/L) 
Pre 20.0 ± 8.3 18.9 ± 4.6 20.9 ± 5.7 0.773 
Post 20.0 ± 7.7 19.8 ± 5.1 22.9 ± 6.8 0.506 
AST (U/L) 
Pre 20.5 ± 4.9 21.4 ± 4.4 22.2 ± 4.5 0.712 
Post 21.2 ± 4.3 20.6 ± 4.3 22.0 ± 2.8 0.690 
Total cholesterol 
(mg/dL) 
Pre 205.0 ± 40.0 220.7 ± 29.2 193.8 ± 41.0 0.258 
0.209 Post 195.2 ± 32.5* 218.6 ± 25.2 203.0 ± 32.3 
HDL-C (mg/dL) 
Pre 57.5 ± 19.5 60.6 ± 13.1 53.4 ± 11.7 0.561 
Post 56.3 ± 17.2 58.9 ± 10.5 52.8 ± 12.4 0.592 
LDL-C (mg/dL)§ 
Pre 121.0 ± 35.1 141.8 ± 26.0 118.9 ± 34.9 0.211 
Post 113.0 ± 28.0 138.5 ± 24.5 121.8 ± 33.4 0.149 
TAG (mg/dL)§ 
Pre 119.6 ± 65.6 91.8 ± 42.2 107.4 ± 40.0 0.466 
Post 126.1 ± 94.0 106.2 ± 48.9* 142.6 ± 68.0 0.509 
CK (U/L)§ 
Pre 77.4 ± 29.7 94.1 ± 52.5 93.3 ± 43.1 0.625 
Post 88.9 ± 24.4 79.0 ± 14.8 97.9 ± 43.9 0.352 
Data are presented as mean ± SD. There was no difference between or within groups in the blood 
marker concentrations except for total cholesterol in Low group and TAG in Med group. † 
denotes p values for between group comparison.* denotes significant difference from pre-study 
values (p<0.05). §: n=9 for Low group for LDL-C and TAG, and n=10 and n=9 respectively for 
Med and High groups for CK due to blood sample availability.  
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Discussion 
The purpose of this study was to evaluate the effects of choline intakes of ~51%, 
~86%, and ~126% of AI for three weeks on neuromuscular responses to four sessions of 
lower body RE in 50-65 year old generally healthy individuals, with a randomized 
double-blind design. Based on our previous findings (76, 89) where lower choline intake 
(~50% of AI) negatively influenced strength and/or lean mass gains after 12 weeks of 
RET, with no additional positive effects of higher choline consumption (~118% of AI), 
it was hypothesized that low choline group would show diminished neuromuscular 
activation, isometric force production, and strength gains compared with higher choline 
intakes. However, there was no difference between choline groups in changes in leg 
press/leg extension 1RMs, average/peak isometric force outputs, or EMG amplitudes. 
It is difficult to identify the reason(s) why there was no effect of varying choline 
intakes on muscle responses in the present study while different amounts of choline 
consumption influenced strength and/or muscle gains in our previous studies. However, 
the differing results may be attributed to the difference in duration of diet 
intervention/study design. In the present study, diet intervention was conducted for three 
weeks whereas participants in our previous studies underwent 12 weeks of diet 
intervention. Even though previous studies by others used mostly endurance exercise as 
the exercise protocols, these studies consistently showed that acute (one time) or short-
term (~2 days) choline supplementation did not have any effects on exercise 
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performance (14-17). The only study that examined the effect of prolonged (four weeks) 
choline supplementation did not observe any effect on exercise performance either (18). 
Moreover, even severely low choline diet (<10% of AI) for 42 days did not result in 
signs of choline deficiency in 6 of 26 men and 3 of 15 postmenopausal women in a 
clinical setting under a sedentary condition (38). It appears that longer than one month of 
time may be needed before differing choline intakes start to show an observable 
difference in muscle responses, probably due to the ability to synthesize choline de novo. 
In addition, difference in methods of choline administration may explain, at least 
in part, why a choline effect was not observed in the present study. Wurtman et al. (95) 
reported that oral intake of lecithin (phosphatidylcholine [PC]) affects blood choline 
levels more effectively than choline chloride in healthy young subjects: Taking 2.3g 
(>400% of AI) of choline as choline chloride after 12 hours of fast increased blood 
choline levels by 86% after 30 minutes of ingestion, which returned to baseline within 
four hours whereas blood choline concentration increased by 265% in one hour after 
taking the equal amount of choline as lecithin, and the increase remained for 12 hours 
(95).  Hirsch et al. (96) also reported that after intake of lecithin, increase in blood 
choline lasted considerably longer than choline chloride consumption (12 hours vs. 4 
hours, respectively). 
The disparity in effectiveness between lecithin/PC and choline salt consumption 
can be explained by the roles that intestinal bacteria play. It is estimated that 
approximately 65% of free choline liberated from choline salts can be converted to 
trimethylamine (TMA) by intestinal (stomach and small intestine) bacteria and excreted 
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in the urine (97) while choline in the form of lecithin/PC is less susceptible to the 
transformation by intestinal bacteria. de La Huerga and Popper (98) reported that 2 g of 
choline from lecithin resulted in considerably lower (1/3) urinary excretion of TMA 
compared with the same amount of choline in the form of choline bicarbonate. The 
consequence of bacterial degradation of choline to TMA and subsequent excretion is 
reduced choline availability for absorption and utilization. 
Therefore, it may be possible that the Med and High groups in the present study 
did not have sufficiently more available choline than the Low group, effectively negating 
the difference in choline intake between groups, because of bacterial degradation of 
choline to TMA, since supplemental choline was provided as choline bitartrate in the 
present study. Considering the fact that vast majority of choline is ingested as 
lecithin/PC, and <1% of the choline exists as free choline in food (95), it is likely that the 
participants in our previous studies that examined the effects of habitual choline intake 
or egg yolk supplementation, consumed choline mostly from PC, thus, more choline was 
absorbed and utilized in the higher choline intake groups, resulting in meaningful 
differences in muscle responses. This also suggests that choline intake in the form of 
whole foods may be more effective and preferable than consumption of choline from 
isolated dietary supplements. While it is generally recommended that healthy dietary 
patterns be achieved through whole foods instead of isolated nutrient or dietary 
supplements (20), the general public appears to value isolated nutrients more than whole 
foods that contain them, which may be problematic (99). 
The present study attempted to determine indirectly whether ACh availability 
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mediated by dietary choline is one of the main mechanisms responsible for choline’s 
effect on muscle responses to RE by measuring surface EMG activities. The electrical 
current detected on the surface of skeletal muscle can represent the activities of motor 
neuron that control muscle contraction via ACh, which may be affected by dietary 
choline, unless there is a problem in electrical conductivity on muscle membranes, 
which is unlikely to occur in most cases since plasmalemmal conduction is properly 
maintained even after high volume, muscle injury-inducing eccentric contractions (71). 
However, no difference in EMG amplitudes was observed between choline 
groups while EMG activities were highly correlated with average and peak isometric 
force production, which were also not different between choline groups, making it 
difficult to draw any conclusion on whether ACh availability is the major mechanism 
responsible for muscle responses to dietary choline and exercise. If there was a 
dissociation  between force outputs and EMG amplitudes (i.e., difference between 
choline groups in force outputs but no difference in EMG amplitudes), it would mean the 
mechanism responsible for the force disparity may be excitation-contraction coupling 
failure (100), rather than ACh. On the contrary, if there was a difference between choline 
groups both in the force outputs and EMG amplitudes, and the two outcome variables 
were highly correlated with each other, it would mean ACh may be the main mechanism 
through which dietary choline influences strength/force production. Since the present 
study observed high correlations between force outputs and EMG amplitudes while there 
was no difference between groups in force production, it is difficult to exclude ACh 
from the list of potential mechanisms. Future studies with longer duration of dietary 
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choline intervention with EMG measurements are warranted to examine the relationship 
between ACh activities, force outputs, and choline intake.   
In addition to muscle responses to choline and exercise, since liver and muscle 
damage as well as perturbed lipoprotein metabolism was associated with a low choline 
diet (37, 38), clinical markers of liver/muscle damage and blood lipid profiles were 
measured in the present study. Consistent with our previous study results (89), there was 
no effect of dietary choline on blood levels of ALT, AST, CK, HDL-C, LDL-C, TAG, or 
total cholesterol (Table 18), confirming that moderately low choline consumption does 
not result in alterations of clinical markers of muscle/liver damage or lipid metabolism. 
In summary, the present study observed that three weeks of choline intakes 
ranging from 51% to 126% of AI did not have any effects on changes in strength and 
neural activation measures such as 1RMs of leg press/leg extension, average/peak 
isometric force outputs, and EMG amplitudes in response to lower body RE in 50-65 
year olds. It appears that only prolonged period of differing choline consumption may be 
able to influence muscle responses and exercise performance. Future studies may be 
needed to examine the roles that intestinal bacteria play in choline metabolism 
associated with exercise. 
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CHAPTER VI 
CONCLUSIONS 
The purpose of this dissertation was to investigate the effects of varying amount 
of choline consumption on muscle responses to resistance exercise in older men and 
women. It was observed in CHAPTER III that mean choline consumption in 60-69 year 
old generally healthy men and women was 304.2 ± 70 mg/day (3.9 ± 0.9 mg/kg/d), 
which is approximately 56% of AI (~7 mg/kg/day; 550 mg/d and 425 mg/d for adult men 
and women, respectively), when they followed a “healthy diet” recommended by the 
American Dietetic Association (ADA, now known as the Academy of Nutrition and 
Dietetics). This was consistent with previously reported choline intake data (313 mg/d in 
the Framingham Offspring Study, 335 mg/d in NHANES 2011-2012; 372 mg/d in men 
and 304 mg/d in women in Yonemori et al.’s study) (22, 45, 48), suggesting that 
inadequate choline intake is prevalent in this age group. The prevalence of low choline 
intakes in older adults may have devastating effects if dietary choline affects responses 
to RE, which is one of the most effective means to delay or counter the effects of aging 
on muscle mass and strength in older men and women (2). 
In CHAPTER III, it was shown that lower choline intake (~49% of AI) was 
associated with significantly reduced gains in strength and lean mass following 12 weeks 
of RET compared with higher choline intakes (63% or 85% of AI), and there was a 
significant linear relationship between choline intake and change in strength in 60-69 
year old men and women. CHAPTER IV also showed that lower intake of choline 
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(~51% of AI) induced significantly diminished strength gains in response to 12 weeks of 
RET compared with higher choline intakes of 68% or 118% of AI in 50-69 year old 
individuals while there was no effect of dietary choline on lean mass gains. Meanwhile, 
choline intake higher than AI did not provide additional positive effect on RET 
responses. It appears that having adequate dietary choline may have a strong effect on 
strength gains and subtle or no effect on lean mass changes. 
With evidence that 12 weeks of low choline intake negatively affects muscle 
responses to RET, CHAPTER V examined whether low choline consumption for a 
shorter period of time (< a month) still impairs muscle responses to resistance exercise in 
older adults. There was no effect of dietary choline on changes in 1RM on leg press/leg 
extension or average/peak isometric force outputs from knee extension in 50-65 year 
olds after three weeks of dietary choline intakes ranging from ~51 to ~126% of AI, 
suggesting that only prolonged period of differing choline consumption may be able to 
influence muscle responses and exercise performance. 
An attempt was made, in CHAPTER V, to determine indirectly whether ACh 
availability mediated by dietary choline is the main mechanism through which choline 
influences muscle responses to RE by measuring surface EMG, since EMG amplitude 
represents the activities of motor neuron and ACh (71, 72, 88). However, no difference 
observed in EMG amplitudes between choline groups and high correlation between 
EMG and maximal isometric forces, which were also not different between choline 
groups, made it difficult to draw any conclusion on whether ACh is the main mechanism 
for muscle responses to dietary choline and RE. 
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It was reported that severely low choline consumption (<10% of AI) causes 
liver/muscle damage and altered lipoprotein/blood lipid metabolism. However, in the 
studies of this dissertation, moderately low choline intake (~50% of AI) did not affect 
blood levels of clinical markers of liver/muscle damage or lipid metabolism while low 
choline intake negatively influenced strength and/or lean mass gains with 12 weeks of 
RET. These results indicate that choline intake levels which are below AI but do not 
present overt clinical signs may still have negative consequences that affect health and 
well-being of older adults. 
Taken together, it was concluded from the observations of this dissertation that 
lower choline consumption (≤ 50% of AI) for 12 weeks may impair strength and/or lean 
mass gains associated with RET while less than a month of low choline intake may not 
have observable effects on muscle responses to RE in generally healthy 50-69 year old 
individuals. The potential mechanisms of these effects of dietary choline may include 
ACh availability at the NMJ, membrane integrity, cell signaling, and/or methylation 
reactions. 
Considering the effects of skeletal muscle on overall health and well-being, 
especially in older population who are exposed to devastating effects of sarcopenia and 
whose choline intake is persistently low, it is important to optimize nutritional factors to 
maximize the benefits of RET which is one of the most effective tools to fight 
sarcopenia with. Future studies are needed to confirm the results of this dissertation and 
if so proven, to elucidate the mechanism through which dietary choline affects skeletal 
muscle responses to RE. 
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